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INTRODUCTION 
The  term ‘PAIN’ gives  the  meaning  as ‘penalty’ derived  from 
term ‘poena’. Pain  is defined as “ an unpleasant emotional or sensory 
experience with associated potential or actual tissue damage or 
described in terms of damage”. 
It is proven fact , that regardless of age , infants and children  
perceive pain. Even a preterm baby has both functional and anatomical 
components required to perceive pain.  They show a severe stress 
response to painful stimuli. 
           Whenever there is a noxious stimuli at the time of injury , it 
induces a local inflammatory response in the periphery, i.e there is 
sensitization of nociceptors  and primary hyperalgesia. 
     The noxious input is conducted to CNS by A delta and C fibers. It 
initiates a sequence of events i.e reflex withdrawal from stimulus, 
aversive behaviour  and  pain perception. 
           The sustained noxious input from C fiber produces central 
sensitization, which in turn alters sensory processing in spinal cord 
finally leading to allodynia and hyperalgesia at the site of injury.  
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           Pathway of pain is illustrated in the figure. There  are  several  
sites  in the pain pathway that can be targeted for the effective treatment  
of  pain .  
 
                At the peripheral level , local  anaesthetics , peripheral  
nerve blockade , NSAIDS , opiods  can  be  used  to  treat  pain . 
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            At  the level of spinal cord  opiods ,  alpha -2 agonists and  local 
anaesthetics  can  be used . 
            At the cortical level , opiods can be used. Mostly combined 
mode  of  therapies  are  used to treat  pain effectively.  
Certain differences in the mechanism of pain response have been 
observed in early life as follows : 
1. In case of neonate , threshold for pain sensation is lower than that 
of adults and they have exaggerated reflex responses. 
2. There is less co-ordination in the motor component of withdrawal 
reflex. There is involvement of whole body movements during 
withdrawal response. 
3. The receptive fields of sensory neurons are comparatively larger 
and there is greater overlapping, which in turn influences sensory 
localization and discrimination. 
4. In case of adults, input from sustained C fiber causes CNS 
stimulation in response to noxious stimuli. Functioning  of A 
delta and C fiber begins to matures after birth and C fiber activity 
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attains maturity much later. In early life , it is the A delta fiber 
which involves in central sensitization rather than C fiber. 
5. There is no complete maturity in peripheral inflammatory 
response at birth. 
ASSESSMENT  OF  PAIN : 
1. Self report measures : eg. VAS , Faces , Manchester pain 
scales. 
2. Observational behavioural  measures : eg. CHEOPS, FLACC, 
Comfort scale 
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“ FLACC Behavioral pain scale: Total Score 0 – 10 
Categories 0 1 2 
Face No expression 
or smile 
Occasional 
grimace, 
withdrawn, 
disinterested 
Frequent to 
constant frown, 
clenched jaw, 
Legs Normal position 
or relaxed 
Uneasy, restless, 
tense 
Kicking or legs 
drawn up 
Activity Lying quietly, 
normal 
position, moves 
easily 
Squirming, 
shifting back 
and forth, tense 
Arched, rigid or 
jerking 
Cry No cry, awake 
or asleep 
Moans or 
whimpers, 
occasional 
complaint 
Crying steadily, 
screams or 
sobs, frequent 
complaints 
Consolability Content, 
relaxed 
Reassured by 
occasional 
touching, 
hugging or 
being talked to 
distractible 
Difficult to 
control of 
comfort ” 
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AIM OF THE STUDY 
This study compares the efficacy of producing postoperative pain 
relief  and safety of using caudal epidural administration of 1ml/kg of 
0.25% levobupivacaine with 0.5mg/kg preservative free ketamine vs 
levobupivacaine alone in 60 children between ages 6months to 8 years 
who underwent lower abdominal surgery. 
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ANATOMY OF CAUDAL EPIDURAL SPACE 
Armitage in 1879 performed the first caudal epidural block. It is 
performed via the sacral hiatus to reach the caudal epidural space. 
This caudal epidural space is clinically significant  because the 
caudal epidural blockade  is  the  most commonly performed technique  
in the paediatric age group  for surgeries  involving  the  perineum , 
lower limb  and  lower  abdominal regions . 
The epidural space can be easily reached via the sacral hiatus 
because  level of termination of duramater of the spinal cord is at the 
level of second sacral segment .  
Beyond the  level  of  second  sacral  vertebra ,  epidural space  
continues .  The  sacral   nerve  roots   and  lower  lumbar  nerve  roots   
are  found  emerging  at  this  level . 
Infiltration  of  the  Local anaesthetic at  this  level  provides  
analgesia  and  anaesthesia  of  perineum . When  the  volume  of  local  
anaesthetic  is  increased  further  it  may  involve  the  lower  lumbar  
roots  as  well .  Large volume of the drugs will extend the effect to the 
lower lumbar roots. 
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ANATOMY OF SACRAL HIATUS 
The sacral  hiatus  is  a  gap  in   the  lower  dorsal   aspect   of   the  
sacrum which   is  usually  triangular  in  shape .  In normal  adult , the  
fifth  and  fourth  sacral  vertebral  arches  fail  to  fuse  dorsally   
leading  to  a ‘ v ’ shaped  opening  known  as  sacral  hiatus.  
 
 
BOUNDARIES  OF  SACRAL  HIATUS :  
Its lateral  margin  is  formed   by  the  sacral cornua, which  is  a  
palpable  bony  margin  of  unfused  lamina  of  5th  sacral  segment. The  
fused lamina of 4 th  sacral segment  forms  the  superior  boundary, 
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while posterior surface of the body of 5th  sacral segmen forms  the   
inferior  boundary.  
 
The  sacral  hiatus  is  covered  dorsally  by  the  continuation  of  
ligamentum  flava  known  as  the  sacrococcygeal  membrane , which  
lies  beneath the  skin  and  subcutaneous  fat.  
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Clinically, it can  be  located  palpating  the depression in between 
the sacral cornua. Certain  factors  like  age and  weight  of  the  patient  
influence  the  distance  to  reach  the  epidural  space  from  the  skin.  
The   apt    size   of   needle   is   25    mm   long   needle.   It   is   
adequate  to  reach  the  sacral  epidural  space  and  can  prevent   
inadvertent  dural  puncture.   
It   is  difficult  to  perform  caudal  epidural  anaesthesia  in  
paediatric  age  group  in  more  than  6 -7  years.  This  is  because  as  
the  age  advances , there  is  change  in  the  axis  of  the sacrum  and  
sacral  hiatus may  close. 
INDICATIONS  AND CONTRAINDICATIONS 
INDICATIONS : 
 Caudal epidural anaesthesia is indicated for  surgeries  below  the  
diaphragm  especially  in  sacral ,  lower  lumbar  areas  and  lower  
limbs  for  example  lower  abdominal  surgical  procedures , including  
inguinal  hernia  repair , urinary  and  lower digestive  tract  surgery  and  
orthopedic procedure on the pelvic girdle and lower extremities. 
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 CONTRA INDICATIONS :   
-  Bleeding diathesis 
-  Sacral  malformations 
-  Raised intra cranial pressure 
- Meningitis 
TECHNIQUE  OF CAUDAL EPIDURAL ANAESTHESIA : 
The  patient   is  placed  in the  lateral  position  with  thighs  
flexed at  right  angles  to  the  hip.  
           The sacral  hiatus is  identified  and  a  22   gauge  short  bevelled 
needle   is  inserted  at  an  angle  of  60  degrees  with  its  apex  until  a  
distinct  pop  is  felt. 
           At  this point the  sacro coccygeal membrane  is  best  felt  by  the  
needle  and is the  deepest  part  of  the  sacral  canal  so  that  the  entire  
bevel  of the  needle  is  within  the  canal. 
           A  longer   bevel   may   be   partly   outside   the   canal  or   may   
traumatise a  vessel  or  periosteum  as  it  is  advanced . 
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           The needle  is  stabilised , careful  aspiration  for  blood  and  
CSF  is  performed  and  the  drug  administerd   in  small aliquots   with   
repeated  aspiration. 
           Careful  observation  of  ECG [ looking  for  doubling  in  size of  
the  T  wave or  tachycardia as  a  sign  of  intravascular  injection ] is  
needed  at  the  time of drug  administration. 
              Some  authors  suggest  decrease  in  angle  of  entry  to  30  to  
45  degrees  and  advancing  a  few  mm. This  may  be  necessary  in  
the  smaller  infants  who  have  a  shallower  canal   or  when  using  a  
longer  bevel  needle , to  ensure  that  the  whole  bevel  is  inside  the  
canal [beware  of  dural  puncture  with  the  longer  bevel  and  this  
technique]. 
               It  is  easier  to  do  the  block  with  saline  filled  2ml  syringe   
with  a  small air  bubble  entrapped  in it  attached  to  the  needle.  This  
is  easier  to  hold  like  a  pen  and  the  position  may  be tested  straight  
away. Free flow  of  saline  without  the  change  in  the  shape  of  the  
air  bubble  confirms  the  correct placement.  
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               Alternatively  a 22 gauge  iv cannula  may  be  used . After  
Puncture  of  sacrococcygeal  membrane , cannula  should easily  slide 
off the  needle into  the  epidural space. 
 
CONTINUOUS  CAUDAL  EPIDURAL BLOCK :     
Indications  are  similar  to  the  single  shot , but  this  block  is  
used   when   the  patient  will  benefit   from  prolonged   analgesia  .  The   
procedure  is  the  same as  described  above  but  the  needle  used  is  
larger. 
           It  should  be  either  a  Crawford needle  or  large  iv  cannula  [ a 
21  gauge  epidural  catheter  will usually  pass  through  a 18  gauge  iv  
cannula  ]  for   the   caudal   approach  ;  a  paediatric   tuohy  needle   may   
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misdirect a caudal  catheter  since  the  tip  directs the  epidural  catheter 
laterally. 
           In all cases , check that the  catheter  will  pass through  the  
needle  and   check  the  length  of  the  needle with  reference to  the  
catheter. Once  the  needle is  in  place , the  catheter  is  advanced  2 to  
3  cms  or more, depending on  the  level  of  block  required. 
           The catheter  tip is  placed  at  or  near  the  midpoint  of  the 
dermatomes  involved in  the  surgical  incisions.  
           Bosenberg et al  have  threaded  catheters up  from  caudal  to  
the  thoracic  level  in  children  less than  6  years  of  age  in order  to  
provide  continuous  thoracic  epidural  analgesia.  
           It  is  possible  however  for  such  catheters  to  become  lodged  
in  a dural  sleeve or  to become kinked.  A post operative   x ray may  
help  to  confirm  correct  placement.   
           A double  occlusive  dressing  should  be  applied  to  reduce  of  
faecal  contamination  of  puncture  site. 
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SELECTION OF DRUG 
Calculation  of  dose  of  local  anaesthetic is  based on  two  
formulae  namely  Modified  Armitage formula and Takasaki’s  formula  
Two  factors  influence  the  drug  dosage to  be administered  for 
caudal  epidural  blockade .They  are  the  volume  of  local  anaesthetic 
[ not concentration ], and epidural  space  volume.  The  volume of  
epidural   space  is   not  a  constant  one.  It  varies   with age.  Among the 
two  formulae , Takasaki’s formula  gives best approximated dose with 
comparatively  better  clinical results. 
‘‘ TAKASAKI’S  FORMULA : 
 Volume (ml) = 0.05ml /kg/dermatome to be blocked ” 
Caudal epidural anaesthesia is basically a single shot technique. 
The dosage of Armitage reminds the most dependable .  
“ARMITAGE’S FORMULA : 
With 0.05 ml/kg all sacral dermatomes are blocked, 1ml/kg sacral 
and lumbar dermatomes are blocked, 1.25ml/kg blocks lower thoracic 
dermatomes.”  However when, 1.5ml/kg is injected there is a danger of 
excessive rostral spread (above T4). 
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The level of block depends on volume of drug infiltrated 
influences  or  in other words determines the block  level . The density 
of block depends upon the concentration of the local anaesthetic, where 
dense blockade is necessary for intraoperative anaesthesia and the 
blockade can be less dense for postoperative analgesia,.  
COMPLICATION 
Accidental  intravascular or intraosseous injection 
Vascular Injury leading to hematoma 
Neural injury 
Infection -  It is of grave concern especially when it occurs in 
either the  subarachoid or the epidural space. 
 Meningitis and epidural abscess   are the most potential serious 
complication. The signs and symptoms are the same for epidural abscess 
and hematoma except fever, raised ESR and leukocyte count which is 
associated with previous one. Whenever a child develops pyrexia  of  
unknown  origin  with  an  indwelling   caudal / epidural  catheter , it is  
mandatory to  remove  the  catheter  immediately. 
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Epidural hematoma is a very rare complication. Rapid diagnosis , 
immediate intervention and decompression  of the hematoma gives 
better  outcomes.  
Patients with clinically  significant bleeding  diathesis , 
thrompocytopenia are  especially  at a very  high  risk of  developing 
epidural  haematoma .These conditions are definitely a contraindication 
to central neuroaxial blockade. 
Another rare complication associated with epidural blockade is 
Urinary retention. with use of opioids. 
Block failure rate is 3 to 5% and failure rate  increases  especially  
in children older than 7years of age. 
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PHARMACOLOGY  OF  LEVOBUPIVACAINE 
It belongs to the  amino amide group  of local  anaesthetics.   
S-enantiomer of Bupivacaine  is known as levobupivacaine. 
It is commercially used in the form of water soluble 
hydrochloride salt solution. 
Levobupivacaine is associated with relatively  longer duration of 
action and vasodilation is less when compared with Bupivacaine. Its 
potency is 13% less than that of Bupivacaine.  
CHEMICAL STRUCTURE :  
It has a hydrophilic and lipophilic portion separated by a 
interconnecting  hydrocarbon chain. 
           The hydrophilic portion is a tertiary amine usually and the  
lipophilic portion has an unsaturated aromatic ring.   
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Bupivacaine  is  available as racemic mixture of levo and dextro 
enantiomer. Levobupivacaine is the levo enantiomer which  produces 
less neuro toxicity and cardio toxicity than dextro enantiomer  and 
racemic mixture.  
PHARMACOLOGICAL  PROFILE  OF LEVO BUPIVACAINE: 
Onset  -  slow 
Duration after infiltration  -  240 - 480  mins 
Maximum single dose for infiltration  -   175 mg 
Toxic plasma concentration  -  >3 micro gram / ml 
Pka  -  8.1 
Protein binding  -  >97% 
 Volume of distribution  -  55 litres 
Elimination  half  life  -  156  mins 
MECHANISM  OF  ACTION : 
It acts by blocking the sodium channels which are ion selective 
and  inhibits the passage of sodium ions through them thereby  
preventing the transmission of nerve impulses. 
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The threshold potential or resting membrane potential is not 
altered . It binds to alpha – subunit of sodium channel whereas beta 
subunit modulate the binding of local anaesthetic to alpha subunit.  
           It also blocks the voltage dependent potassium ion channels but 
with a lower affinity.This explains the broadening of action potential. 
PHARMACO KINETICS : 
The rate of tissue distribution and rate of clearance of the drug 
influences its plasma concentration. 
           Also, the tissue blood flow, lipid solubility, patient related factors 
like age, hepatic function,cardiovascular status influence absorption and 
plasma concentration.  
           It is more widely distributed in tissues than the ester group. 
Protein binding influences  distribution and excretion of drug. Protein 
binding parallels lipid solubility,both are inversely related to plasma 
concentration of drug. 
          It is extracted by lung after instillation, limiting the concentration 
reaching the cerebral and coronary circulation. This pulmonary 
extraction is dose dependent. 
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METABOLISM : 
It is  metabolised mainly in the liver by microsomal enzymes. 
Levobupivacaine undergoes slowest metabolism among amide group, 
leading to sustained increase of plasma concentration. 
           It is metabolised by aromatic hydroxylation . N – dealkylation, 
amide hydrolysis  and conjugation. 
           After regional anaesthesia, N- dealkylated metabolite N-desbutyl 
bupivacaine can be measured in urine or blood.  
           The important plasma protein binding site of levobupivacaine is 
alpha-1 acid glycoprotein.  
ADVERSE  EFFECTS : 
ALLERGIC  REACTIONS : 
It is usually due to usage of methylparaben or similar substances 
in preservatives used in commercial preparations, which are structurally 
similar to para amino benzoic acid. 
           It is due to prior stimulation of antibody production by 
preservatives. Cross sensitivity can occur between local anaesthetics 
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belonging to same group because of common metabolite para amino 
benzoic acid. 
SYSTEMIC TOXICITY : 
It is due to excess plasma concentration of Levobupivacaine. It 
depends on the rate of drug introduced, redistribution and clearance of 
the drug. Accidental direct intravascular injection  produces excess 
plasma concentration. 
When the plasma concentration is more than 2 – 2.5 microgm / 
ml, CNS toxicity occurs. Cardiac and CNS toxicity occur 
simultaneously in paediatric age group because plasma protein binding 
is lower. It crosses blood brain barrier and CNS function is altered. 
As the plasma concentration increases, sequence of symptoms 
manifest usually. But in case of paediatric age group,it is not as 
obviously seen as in adults.  
The  threshold for cardiac toxicity is lower for  levobupivacaine  
in case  of  paediatric age group. Therefore both CNS and cardiac 
toxicity occur concurrently in infants and children. Sometimes CNS 
toxicity is preceeded by Cardiac toxicity. 
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           When volatile anaesthetics are used concomitantly, the risk of 
cardiac toxicity is increased. Moreover general anaesthetic effects over 
CNS will obscure signs of CNS toxicity. 
           In case of adults, first and foremost symptom is circumoral 
paresthesia due to high tissue concentration. It is followed by dizziness, 
light headedness, visual and auditory disturbances. 
           Shivering , muscle twitching, and slurred speech are the signs of 
CNS toxicity. When the plasma concentration increases further,it results 
in generalized seizures due to CNS excitation.  
           Further increase in plasma concentration depresses the CNS, 
leading to respiratory depression and respiratory arrest. CNS toxicity is 
followed by cardiovascular toxicity in adults.  
           There is also role of slow or flicker potassium channels in 
Levobupivacaine toxicity. 
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PHARMACOLOGY   OF  KETAMINE 
   Ketamine is an aryl cyclo hexyl amine, a congener of 
Phencyclidine. It is available as R+ and S- isomers. The S isomer form 
is more potent with fewer  side effects. 
   It is readily water soluble even though it is lipophilic. It is 
available as sodium chloride solutions both with and without 
preservatives. Preservative used is benzethonium  chloride. 
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PHARMACO KINETICS : 
 I V Induction dose – 1 – 2 mg / kg 
    pH – 3.5 – 5.5 
    Minimum hypnotic level – 1 micro gm/ ml 
Induction dose duration – 10 – 15 mins 
Half – life  -  3 hours 
Clearance  - 19.1 ml / min / kg 
 Protein binding capacity – 27  % 
Volume  of distribution – 3.1 litre / kg 
Distribution half life – 10 – 15 mins 
Ketamine is metabolized in liver to nor ketamine,which has less 
CNS effects. It is further metabolised and excreted in bile and urine. It 
has rapid clearance and large volume of distribution . So it convenient to 
use it as continuous infusion.  
It is typically administered intravenously but also effective by i.m, 
oral, rectal and epidural routes. 
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MECHANISM  OF  ACTION : 
Ketamine predominantly inhibits excitatory neuro transmission at 
glutaminergic  synapses. It  inhibits the ligand gated cationic channel, 
the N – methyl  D- aspartate [ NMDA ] receptor by binding to the 
phencyclidine site.  
The  NMDA receptors , glutamate gated cationic channels 
involved in long term modulation of synaptic responses  and glutamate 
mediated neurotoxicity.  
The thalamus relays sensory impulses from reticular activating 
system to cerebral cortex , ketamine functionally  dissociates  the 
thalamus in contrast to barbiturates.  
EFFECT  ON  VARIOUS  SYSTEMS : 
CENTRAL NERVOUS SYSTEM:     
Ketamine  raises the intracranial blood pressure and increase the 
cerebral blood flow. It also increases the cerebral metabolic rate in 
anterior cingulate, frontal cortex, thalamus and putamen.   
27 
It is contraindicated in patients with intracranial pathology or 
cerebral ischemia as the S ketamine increases the CBF and ICP  while   
R+ decreases CBF and ICP. 
It also increases intraocular pressure thus it is not used in patient 
with open eye injury. It can cause emergence delirium, hallucinations, 
vivid dream  and delusions. It rapidly produces a hypnotic state. 
Patient remain unresponsive to commands and amnesia with 
profound analgesia, but they may  moves their limbs, open their eyes 
involuntarily and have a spontaneous breathing. 
          It induces a cataleptic state  which is accompanied by , salivation, 
lacrimation, spontaneous limb moments with increased muscle tone, 
nystagmus and pupillary dilatation This cataleptic state has been termed 
as Dissociative Anesthesia.  
          It reduces the development of tolerance to long term opioid use. 
So, low-dose ketamine infusion can be used in patient who have 
developed siginificant opioid tolerance.  
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CARDIOVASCULAR SYSTEM: 
Ketamine has indirect sympathomimetic activity and it can be 
used in patient at risk of developing hypotension. 
It  indirectly inhibits both central and peripheral catcholamine 
reuptake, thus it increases BP, heart rate, cardiac output. It increases 
myocardial O2 consumption   and thus it is not used for patient at risk 
for MI.  
RESPIRATORY SYSTEM: 
Induction dose produce small and transient decrease in minute 
ventilation but cause less severe respiratory depression. It is a potent 
bronchodilator due to indirect sympathomimetic activity and thus it is 
used in patients at risk for bronchospasm . 
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REVIEW  OF  LITERATURE 
1.Locatelli et al4 did a randomised study to evaluate the post op 
pain relief after lower abdominal surgery with adding ketamine 0.5 mg / 
kg allows a lower concentration of levobupivacaine in caudal block 
without loss of clinical effectiveness. 164 children [ASA 1 or 2 ] aged 
three months to 6 years randomly allocated to receive 1 ml / kg of 
levobupivacaine 0.15% with 0.5 mg / kg s(+) ketamine [ group 1 ], 
levobupivacaine 0.175% with 0.5 mg / kg s (+) ketamine [ group 2 ] or 
levobupivacaine 0.2 % [ group 3 ] by caudal epidural route. 
During the first 6 hours after surgery  Pain, sedation, motor block 
and postoperative analgesia requirement were assessed. The  
effectiveness of the drugs showed no significant difference between 
groups at first surgical incision.  
          During the post operative period ,it  was found that  there was  
significant lower analgesic requirement in group 2 compared with group 
3. First rescue analgesia time was found to be longer in group 2 in 
comparison to  group 1 and 3.In ketamine groups , no dysphoric reaction 
or excessive  sedation  was observed in the ketamine groups. 
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2.Marhofer et al5 did a prospective randomised study to evaluate 
the intra  and post operative analgesic efficacy of preservative free s(+) 
ketamine compared with bupivacaine for caudal epidural block in 
paediatric hernia repair. 
After induction , 49 children undergoing hernia repair were given, 
a caudal epidural injection ( 0.75 ml/kg ) of s (+) ketamine 0.5 mg/kg [ 
group k1] , s(+) ketamine 1mg/kg [group k2] or 0.25% bupivacaine with 
adrenaline 1: 200000 [ group B ].    
There was no requirement of any  additional analgesic drugs 
during operation in all the groups. During the observation period 
Haemodynamic status and respiratory variables  was found to be stable.  
In group B and k2 the mean duration of analgesia was found to be 
longer compared with group k1. The requirement for analgesics  in the  
post  operative period  was found to be  less  in  Groups k2 and B when 
compared with group k1 [ 30% and 33% Vs 72%,p <0.05 ].  
Post operative sedation scores of all the three groups were 
comparable. In conclusion of his study , he found  that s(+) ketamine 1 
mg/kg for caudal epidural block in paediatric surgical and post operative 
analgesia  was found to be equivalent to that of bupivacaine. 
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3.Martindale et al6 performed a randomized  double blinded  
controlled trial of caudal Vs intravenous s(+) ketamine in children for 
lower abdominal surgery for supplementation of caudal analgesia. 
           60 children randomly allocated into three groups of children , 
group 1 received  plain bupivacaine 0.25% 1ml/kg , group 2 received 
caudal plain bupivacaine 0.25% 1ml/kg with s(+) ketamine 0.5 mg /kg, 
group 3 received caudal plain bupivacaine 0.25 %  1ml/kg plus s(+) 
ketamine 0.5 mg/kg iv.  
           In group 2 [ 10 hours ] those received caudal ketamine the 
median time to first analgesia was significantly longer than in the iv 
ketamine [ 4. 63 hours ] or bupivacaine [4.75 hours]  groups  [p=0.01]. 
           During the first 2 hours, it was found that less doses  of analgesia 
were  required for the caudal ketamine  group [median 1] compared with 
iv ketamine [median 2] or bupivacaine [median 2.5] groups [p<0.05]. 
           The groups  showed no difference among themselves in the 
incidence of postoperative nausea , vomiting and psychomotor 
reactions.  
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4.  Ivani  et  al7 did a prospective , randomised double blinded 
study in caudal block for children[age of 1-7 yrs] who are] undergoing 
subumblical surgery,  with three different concentration of 
levobupivacaine [ 0.125%, 0.20% and 0.25%, n=20 in each group.  
           The duration of postoperative analgesia was assessed as by the 
time taken for requirement for  1st administration of supplemental 
analgesia drugs [ based on CHIPPS score of ->4 ] and the degree of 
immediate postoperative motor blockade, it was determined by use of a 
3 point scale. 
           A dose response relationship was observed both with regard to 
median duration of the number of patient with evidence of duration of 
the number of patient with evidence of early post operative motor 
blockade [0.125%,0 ; 0.20%, 4; 0.25%,8] and post operative analgesia 
[0.125%,60 min,0.20%,118 mins, 0.25%, 158 mins].  
           The 0.125% concentration levobupivacaine was associate with 
significantly less early motor blockade [p=0.003] but was found to result 
in a significantly less duration of postoperative analgesia [p<0.05]. 
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           Based on these results , the use of 0.25% levobupivacaine might 
represent the best clinical option for caudal block if a plain 
levobupivacaine solution is to be used. 
5. Pablo imgelmo et al9  did prospective , randomised double 
blinded study to determine the minimum local analgesic concentrations 
of a caudal block single shot of ropivacaine and levobupivacaine in 
children and to describe the upper dose response curve . 
           It was performed in two phases. In phase 1, 80  children 
randomized to receive either levobupivacaine or ropivacaine. In 2nd 
phase , a further 32 patients were randomly allocated to receive caudal 
anaesthesia with doses designed to determine the upper dose response 
range [the 50% effective dose {ED 50}- ED95].  
           There was no significant difference in ED50 values for caudal 
levobupivacaine and ropivacaine. The ED50 for ropivacaine estimated 
from the Dixon Massey method was 0.075%  and for levobupivacaine 
was 0.069%. 
Estimated by isotonic regression, the ED50 and ED95 
respectively of ropivacaine were 0.066[0.033 – 0.098] and 0.225. For 
levobupivacaine  ED50 and ED95 were 0.068 and 0.20 %. There was no 
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significant differences in the ED50 for caudal ropivacaine and 
levobupivacaine. The potency ratio at ED50 was 0.92 and ED95 was 
0.89, indicating that caudal levobupivacaine and ropivacaine have a 
similar potency. 
6. Cook B et al1, conducted a study in 60 boys aged 1-10 years 
undergoing orchidopexy , who were randomly allocated into three 
groups , comparing the effects of adrenaline 5 microgm/ml, clonidine 2 
microgm/kg or ketamine (0.5 mg/kg) when added an adjuvant to 0.25% 
plain bupivacaine 1ml/kg. 
           Using modified objective pain score, Post operative pain was 
assessed. He found that the mean duration of analgesia was 12.5 hours, , 
5.8 hours, and 3.2 hours in groups  which received ketamine, clonidine  
and  in the group which received adrenaline respectively. 
           It was found that there were no difference between the groups  in 
the incidence of motor block, urinary retention or post operative 
sedation. 
7.Naqub  et al8 performed  a  double blinded randomised study in 
children undergoing inguinal herniotomy  to compare the analgesic 
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effects of bupivacaine 0.25% [ 1ml/kg ] with  or without  ketamine 0.5 
mg/kg.  
           They found  no significant difference in the quality of analgesia 
between the groups. Only 7 % of patients who received the ketamine/ 
bupivacaine combination required further analgesia during the first 24 
hours after surgery, compared with 20%  and 50 % respectively of 
children in the ketamine only and bupivacaine only groups. 
8. Locatelli  et al10 did a randomzised double blinded phase 3 
control  trial comparing levobupivacaine 0.25 % , ropivacaine 0.25% 
and bupivacaine 0.25% by the caudal route in children. 
           99 ASA 1 & 2 children <10 year old scheduled for elective lower 
abdominal surgery were randomised  to receive caudal block with 
bupivacaine 0.25%, ropivacaine 0.25%, or levobupivacaine 0.25%. 
           There was no significant differences in the analgesia onset time 
of the caudal block. Bupivacaine produced a significant incidence of 
residual motor block [ p < 0.01 ] at wake up and long duration of post 
operative analgesia. Compared with other groups [p= 0.03]. 
9. Chalkeadis et al11 did a study to know the pharmacokinetics of 
levobupivacaine 0.25% following caudal administration in children 
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below 2 years of age. A open label phase 2 study was undertaken to 
examine the pharmacokinetics of levobupivacaine 0.25% , 2 mg/kg  in 
49 children below 2 years of age.  
           After single shot caudal epidural administration, plasma 
concentration of levobupivacaine were determined at interval upto 60 
mins after caudal injection. Peak plasma concentration ranged between 
0.41 and 2.12 micro gm/ml.  
           After the caudal epidural administration of levobupivacaine 
2mg/kg in children < 2 years of age, peak plasma concentration was 
within the accepted safe range for levobupivacaine.  
           Time taken to attain peak plasma concentration varied and 
occurred later than 60 mins in some children ,  particularly those aged 
<3 months. Sampling in future pharmacokinetics studies in this age 
group should extend beyond 60 minutes. 
10.  Kumar  et  al12 did a prospective randomized double blinded 
clinical study to compare the efficacy of ketamine [0.5 mg/kg] , 
midazolam [50 microgm/kg ] and neostigmine [ 2 microgm/kg ] co 
administered with bupivacainein caudal epidural anaesthesia for 
unilateral inguinal herniotomy surgery. 
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           80  ASA  1  children  aged  5  to  10  years  posted   for  unilateral  
inguinal herniotomy were randomly allocated into 4 groups [n=20]. 
Duration  of analgesia in the post operative period was longer for 
bupivacaine and neostigmine group and bupivacaine  midazolam group  
compared to other groups. 
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MATERIAL  &  STUDY 
The study was conducted with the approval of ethical committee 
and written informed consent of parents or guardian. 
INCLUSION CRTERIA: 
Age: 6months to 8 Year 
ASA: 1 & 2 
Surgery: Elective lower abdominal surgery  
Duration: Less than 120 minutes 
EXCLUSION CRITERIA: 
Patient with suspected coagulopathy 
Uncontrolled systemic disorders  
Infection at the site of caudal block  
Known allergic to study drugs 
Patient with skeletal deformities 
H/O developmental delay & Neurological disease 
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MATERIALS USED:         
Laryngoscopes of various sizes 
Bougie 
 Oropharyngeal  airway  
Drugs- Atropine, fentanyl, propofol, preservative free  ketamine,             
levobupivacaine, distilled water, ringer lactate, sevoflurane and other 
emergency drugs 
Monitors –ECG, NIBP, SPO2       
2 cc, 5 cc 10 cc syringe        
22G intravenous cannula.        
Appropriate size LMA        
Weighing machine  
  A randomized controlled study was done to compare caudal 
epidural analgesia with 1ml/kg of 0.25% levobupivacaine with 
0.5mg/kg preservative free ketamine vs levobupivacaine alone. 
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The clinical study was conducted at institute of child health, 
anaesthesiology department between September 2012 and October 
2012. Sixty children between age group 6month.. to 8 year scheduled 
for elective lower abdominal surgeries were randomly divided into two 
groups for study. The age and weight of each child was recorded. All the 
children had their last feed at about 3am in the morning. 
GROUP L: 
Received caudal epidural block with 1ml/kg of 0.25% 
levobupivacaine with 0.5mg/kg   preservative free ketamine. 
GROUP K: 
Received caudal epidural block with 1ml/kg of 0.25% 
levobupivacaine alone. 
All the operation were carried out under general anesthesia. 
 Intravenous line was secured with 22G iv cannula on to a vein on 
their dorsum of hand. 
Premedication of injection fentanyl 2microgram/kg was 
administered. Anesthesia was induced in the theatre with titrated doses 
of injection propofol along with N2O, O2 50:50 with sevoflurane 1%.  
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Precordial stethoscope pulse oximeter, NIBP, ECG, SPO2 monitors 
were attached. 
 In appropriate size LMA was positioned in situ, bilateral air entry 
was checked and LMA was fixed, anesthesia was maintained with 67% 
N2O and 33% O2 and sevoflurane 1 to 2% using Jackson Rees 
modification of Ayre’s Tpiece with spontaneous respiration. 
 After induction of general anastheisa, Group L children received 
caudal epidural block with 1ml/kg of 0.25% levobupivacaine with 
0.5mg/kg   preservative free ketamine and Group K  children received 
caudal epidural block with 1ml/kg of 0.25% levobupivacaine alone 
using 23G needle. Intraoperatively ringer lactate solution was infused.  
Heart rate,SPO2, BP were recorded at an interval of 5mins. 
Children were extubated in deep plane of anesthesia. 
 Children remained in the recovery room until they were fully 
awake and then shifted to the post operative ward. The children were 
assessed by the staff nurse who was not aware of group allocation. 
 Assessment of pain, sedation, pulse rate, BP, SPO2 and 
complication like nausea and vomiting, respiratory depression, urinary 
retention, etc., was done at 0,1/2,1,2,3,4,5,6,8,10,12 hrs post operatively. 
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Pain was assessed using FLACC pain scale and rescue analgesia of 
syrup paracetemol 15mg/kg given at pain score 4 or above.  
Oral feeds were allowed after 6 hrs. All children were examined 
prior to discharge for clinical evaluation of neurological system.  
Sedation was assessed using Ramsay sedation score as follows. 
“Score Clinical description  
I Anxious and agitated 
II Cooperative, oriented, tranquil 
III Respond only to verbal commands  
IV Asleep with brisk response to light stimuli 
V Asleep with sluggish response to stimuli 
VI  Asleep without response stimuli” 
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OBSERVATION AND RESULTS 
Statistical analysis  was  done using  statistical package  for  
social sciences [ SPSS for windows , version 16 ] 
           This study is a prospective randomized double blinded study 
done to assess the  effect of Preservative Free Ketamine with 
Levobupivacaine for Caudal Block in Lower Abdominal Surgeries in 
Children. It  was conducted on 60 children admitted for lower 
abdominal surgery at the Institute of child health, a tertiary hospital.  
The  primary outcome was measured as time  duration of post 
operative analgesia and  the secondary outcome  was  measured  by  
haemodynamic changes [ heart rate , blood pressure ]  in intra operative 
and post operative period. 
The following observations were made. The quantitative data are 
expressed as mean (standard deviation) and median and the qualitative 
data as frequency.  
The significant difference between two anaesthetic groups was 
found using Independent Sample T Test (Unpaired Student T Test) for 
quantitative data like age, weight, intra operative and post operative 
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Blood Pressure, intra operative and post operative Pulse rate and 
duration of rescue analgesia. Mann Whitney U Test was used for ordinal 
data like post operative FLACC pain score and post-operative Ramsay 
Sedation Scale. 
Qualitative data like type of surgery, post operative complications 
were analysed using chi square and fisher’s exact test wherever 
appropriate. 
Table No 1: Age distribution of the studied population: 
Age distribution Number of children % 
<2 9 15.0 
2-4 22 36.7 
4-6 12 20.0 
>6 17 28.3 
Total 60 100.0 
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The above table shows that about one third (36.7%) of the 
children fall under age group between 2 to 4 where as about half 
(48.3%) are older than 4 years of age. 
Figure 1: Age distribution of the studied population 
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Table No 2: Gender wise distribution of the studied population: 
Gender Frequency % 
Females 3 5.0 
Males 57 95.0 
Total 60 100.0 
 
Most of the studied children are males (95%) while female children 
contributed only 5% to the study. 
Figure No 2: Gender wise distribution of the studied population 
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Table No 3: Baseline characteristics 
Characteristics Mean Std Deviation 
Age 3.925 2.174 
Weight 13 4 
 
The mean (Std Deviation) of the baseline characteristics age and 
weight are 3.925 (2.174) and 13 (4) respectively. 
Table No 4: Type of Surgery performed: 
Surgery Frequency Percent 
Hydrocele 31 51.7 
Inguinal Hernia 29 48.3 
Total 60 100.0 
 
Half of the surgery was performed for Congenital Hydrocoele 
(51.7%) and the other half for Inguinal Hernia repair (48.3%) 
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Figure No 4: Type of Surgery performed 
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Table No 5: Post operative complications observed in the patients: 
Complications Frequency Percent 
None 49 81.7 
Urinary retention 6 10.0 
Both nausea and vomiting 5 8.3 
Total 60 100.0 
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In 81.7% of the patients no post operative complications were 
observed while urinary retention was observed in 10% of the patients 
and the remaining 8.3% complained of both nausea and vomiting. 
Figure No 5: Post operative complications observed in the patients 
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Table No 6: Patient characteristics – Age  
(Independent Samples tTest). 
Group N Mean 
Std. 
Deviation 
T 
p 
value 
95% 
Confidence 
Interval 
Lower Upper 
Levobupivacaine 30 3.200 1.8551 
-2.719 .009 -2.5174 -.3826 
Ketamine 30 4.650 2.2558 
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Table No 7: Patient characteristics – Weight  
(Independent Samples Test). 
Group N Mean 
Std. 
Deviation 
T 
p 
value 
95% Confidence 
Interval 
Lower Upper 
Levobupivacaine 30 11.9000 3.69856 
-2.408 .019 -3.96804 -.36529 
Ketamine 30 14.0667 3.25823 
 
Both were comparable with respect to their age and weight 
characteristics. The t test reveals a statistically reliable difference 
between the mean age of children belonging to Levobupivacaine group 
(M= 3.2, s.d= 1.8551) and ketamine group (M=4.650, s.d= 2.258), 
t=2.719, p= 0.009, Į=0.05. 
It also reveals a statistically reliable difference between the mean 
weight of children belonging to Levobupivacaine group (M= 11.9, s.d= 
3.658) and ketamine group (M=14.06, s.d=3.258), t=2.408, p= 0.019, 
Į=0.05. 
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Figure No 6: Patient characteristics – Age and Weight 
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Table No 8: Patient characteristics – Duration of surgery 
(Independent Samples Test). 
Group N Mean 
Std. 
Deviation 
T 
p 
value 
95% 
Confidence 
Interval  
Lower Upper 
Levobupivacaine 30 29.83 9.603 -
1.806 
.076 
-
10.895 
.561 
Ketamine 30 35.00 12.387 
 
52 
The mean (S.D) of the duration of surgery for Levobupivacaine 
and Ketamine group are 29.83 (9.603) and 35.00 (12.387) respectively. 
The t-test failed to reveal a statistically reliable difference in the mean 
duration of surgery between the 2 groups. 
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Table No 9: Patient characteristics – Gender 
Gender Ketamine Levobupivacaine Total 
Females 
1(33.33) 
{3.33} 
2(67.33) 
{6.67} 
3 (100) 
{5} 
Males 
29(50.87) 
{96.33} 
28 (49.13) 
{93.33} 
57 (100) 
{95} 
Total 
30 (50) 
{100} 
30 (50) 
{100} 
60 (100) 
{100} 
Fisher’s Exact Test: 1.000 
p.s: () – indicates row percentage; {} – indicates column percentage 
The above table shows that the two different anaesthesia was 
equally given among males whereas one third (33.33%) of the females 
were given ketamine group of anaesthesia.There is no statistically 
significant relation between the Gender of the studied subjects and the 
type of anaesthesia given. (p= 1.00) 
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Figure No 7: Patient characteristics – Gender 
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Table No 10: Post operative complications observed with the two 
groups of anaesthesia 
Post Op Complications L K Total 
Present Urinary 
retention 
3 3 6 
Both Nausea 
&Vomitting 
1 4 5 
Total 4 (36.36) 
   {13.33} 
7 (63.64) 
   {23.33} 
11 (100) 
   {18.33} 
Absent 26 (53.06) 
   {86.67} 
23 (46.94) 
   {76.67} 
49 (100) 
   {91.67} 
Total 30 (50) 
   {100} 
30 (50) 
   {100} 
60 (100) 
   {100} 
Fisher’s Exact Test: 0.5602 
p.s: () – indicates row percentage; {} – indicates column percentage 
One fifth (18.33%) of the children experienced post operative 
complications and among them nearly two third (63.64%) children were 
administered ketamine group of anaesthesia intra operatively. Fisher’s 
exact test didn’t reveal any statistically significant relation between the 
type of anaesthesia with the occurrence of post operative complications. 
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Figure No 8: Post operative complications observed with the two 
groups of anaesthesia 
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Table No 11: Intra operative MAP (Independent Samples Test). 
Time Group N Mean 
Std. 
Deviation 
T 
p 
value 
95% Confidence 
Interval 
Lower Upper 
O min 
Levobupivacaine 30 73.9556 6.96611 
-1.953 .056 -9.40466 .11578 
Ketamine 30 78.6000 11.00588 
5 min 
Levobupivacaine 30 68.7000 7.79839 
-1.172 .246 -8.09467 2.11689 
Ketamine 30 71.6889 11.59169 
10 
min 
Levobupivacaine 30 68.6333 6.06248 
-.698 .488 -5.19905 2.51016 
Ketamine 30 69.9778 8.63075 
15 
min 
Levobupivacaine 30 67.0222 4.86203 
-.952 .345 -5.34246 1.89802 
Ketamine 30 68.7444 8.63064 
20 
min 
Levobupivacaine 30 65.4889 4.70651 
-.990 .326 -5.33778 1.80444 
Ketamine 30 67.2556 8.56335 
25 
min 
Levobupivacaine 22 63.8788 5.26800 
-1.412 .165 -6.41898 1.12527 
Ketamine 26 66.5256 7.32738 
30 
min 
Levobupivacaine 15 63.7333 5.72962 
-1.235 .225 -7.04602 1.71903 
Ketamine 21 66.3968 6.79675 
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35 
min 
Levobupivacaine 11 62.3030 5.55669 
-2.519 .019 -11.28583 -1.10811 
Ketamine 14 68.5000 6.49622 
40 
min 
Levobupivacaine 5 61.0667 8.22733 
-1.969 .071 -15.02855 .69522 
Ketamine 10 68.2333 5.80347 
45 
min 
Levobupivacaine 3 57.7778 2.77555 
-2.796 .023 -17.08914 -1.64102 
Ketamine 7 67.1429 5.37090 
60 
min 
Levobupivacaine 1 55.3333  
-3.189 .050 -17.98046 -.01954 
Ketamine 4 64.3333 2.52396 
 
The above table shows that the mean intra operative Mean 
Arterial Pressure (MAP) measured was higher in the Ketamine 
anaesthesia group both before the surgery and also at all times in the 
intra operative period. The t test revealed statistically significant 
difference in the mean intra operative Mean Arterial Pressure (MAP) 
between the Levobupivacaine group and the ketamine group measured 
at 35 min (p=0.019), 45 min (p=0.023) and 60 min (p=0.050). 
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Figure No 9: Intra operative MAP. 
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Table No 12: Intra operative PR (Independent Samplest Test). 
Time Group N Mean 
Std. 
Deviation 
t 
p 
value 
95% 
Confidence 
Interval 
Lower Upper 
O min 
Levobupivacaine 30 123.60 11.236 
4.863 .000 8.276 19.857 
Ketamine 30 109.53 11.172 
5 min 
Levobupivacaine 30 122.20 9.423 
-.523 .603 -85.924 50.324 
Ketamine 30 140.00 186.167 
10 min 
Levobupivacaine 30 115.77 10.074 
3.640 .001 4.636 15.964 
Ketamine 30 105.47 11.779 
15 min 
Levobupivacaine 30 112.30 9.037 
3.848 .000 4.830 15.303 
Ketamine 30 102.23 11.119 
20 min 
Levobupivacaine 30 108.83 8.363 
3.839 .000 4.611 14.656 
Ketamine 30 99.20 10.905 
25 min 
Levobupivacaine 22 106.00 8.000 
2.441 .019 1.241 12.913 
Ketamine 26 98.92 11.426 
30 min 
Levobupivacaine 15 103.53 8.935 
1.645 .109 -1.525 14.497 
Ketamine 21 97.05 13.238 
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35 min 
Levobupivacaine 11 102.36 8.958 
.814 .424 -5.840 13.425 
Ketamine 14 98.57 13.213 
40 min 
Levobupivacaine 5 97.40 11.216 
-.075 .941 -14.836 13.836 
Ketamine 10 97.90 12.494 
45 min 
Levobupivacaine 3 93.00 6.083 
-.580 .578 -17.779 10.636 
Ketamine 7 96.57 9.693 
60 min 
Levobupivacaine 1 92.00 . 
-.299 .785 -52.457 43.457 
Ketamine 4 96.50 13.478 
 
The mean Pulse rate was lower in the ketamine group before the 
surgery and also between 10th min  to  35th min of surgery whereas at 
other times the Pulse rate Levobupivacaine group was higher.  
The t test revealed a statistically significant difference in the mean 
pulse rate between  the two groups at the commencement of surgery 0 
min  (p= 0.000), 10 min (p= 0.001), 15 min (p= 0.000), 20 min (p= 
0.000), 25 (p= 0.019). 
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Figure No 10: Intra operative PR 
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Table No 13: Post-operative MAP (Independent Samples tTest). 
Time Group N Mean 
Std. 
Deviation 
t 
p 
value 
95% Confidence 
Interval 
Lower Upper 
30 min 
Levobupivacaine 30 64.1333 4.47608 -
1.971 
.054 -5.64366 .04366 
Ketamine 30 66.9333 6.36465 
1 Hr 
Levobupivacaine 30 64.3111 4.26600 -
2.124 
.038 -5.58965 -.16591 
Ketamine 30 67.1889 6.07153 
2 Hr 
Levobupivacaine 30 65.3000 3.83106 -
2.243 
.029 -5.27814 -.29964 
Ketamine 30 68.0889 5.63169 
3 Hr 
Levobupivacaine 30 66.5111 4.04452 -
1.977 
.053 -4.91930 .03041 
Ketamine 30 68.9556 5.43138 
4 Hr 
Levobupivacaine 30 67.8111 4.45985 -
1.733 
.088 -4.81326 .34660 
Ketamine 30 70.0444 5.47214 
5 Hr 
Levobupivacaine 28 68.9524 4.82766 -
1.438 
.156 -4.79299 .78665 
Ketamine 30 70.9556 5.70456 
6 Hr 
Levobupivacaine 19 70.1228 5.41854 -
1.290 
.203 -5.34578 1.16917 
Ketamine 30 72.2111 5.58630 
8 Hr 
Levobupivacaine 7 70.7143 7.21220 -
1.199 
.238 -7.97979 2.05281 
Ketamine 30 73.6778 5.57326 
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This table on the mean post-operative Mean Arterial Pressure 
(MAP) shows that children subjected to ketamine anaesthesia had an 
higher MAP compared with the other Levobupivacaine group 
throughout the post-operative period. 
The independent samples t test revealed a statistically significant 
difference in the mean Mean Arterial Pressure (MAP) measured in the 
1st (p=0.038) and 2nd (p=0.029) hour in the post-operative period.  
Figure No 11: Post-operative MAP 
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Table No 14: Post operativePR (Independent Samples Test). 
Time Group N Mean Std. Deviation T 
p 
value 
95% 
Confidence 
Interval 
Lower Upper 
30 min 
Levobupivacaine 30 106.07 8.047 
2.819 .007 2.096 12.370 
Ketamine 30 98.83 11.525 
1 Hr 
Levobupivacaine 30 104.60 7.351 
3.145 .003 2.677 12.056 
Ketamine 30 97.23 10.517 
2 Hr 
Levobupivacaine 30 104.03 6.646 
2.891 .005 2.062 11.338 
Ketamine 30 97.33 10.813 
3 Hr 
Levobupivacaine 30 105.03 7.209 
3.240 .002 2.662 11.271 
Ketamine 30 98.07 9.314 
4 Hr 
Levobupivacaine 30 107.67 8.949 
3.713 .000 4.025 13.441 
Ketamine 30 98.93 9.266 
5 Hr 
Levobupivacaine 28 109.07 8.326 
3.882 .000 4.358 13.651 
Ketamine 30 100.07 9.270 
6 Hr 
Levobupivacaine 19 111.74 7.600 
3.926 .000 4.927 15.280 
Ketamine 30 101.63 9.434 
8 Hr 
Levobupivacaine 7 113.86 9.388 
2.743 .010 2.578 17.269 
Ketamine 30 103.93 8.452 
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The mean post-operative pulse rate was lower with the ketamine 
group anaesthesia administered children than the other group. 
           The t-test showed a statistically significant difference in the pulse 
rate measured throughout the post-operative period at 30 min (p=0.007), 
1stHr  (p=0.003), 2ndHr  (p=0.005), 3rdHr  (p=0.002), 4thHr  (p=0.000), 
5thHr (p=0.000), 6thHr (p=0.000) and 8thhr (p=0.010). 
Figure No 12: Post operative PR 
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Table No 15: Post operative FLACC pain score (Mann-Whitney Test). 
Time Group N 
Mean 
Rank 
Mann-
Whitney 
Test 
Pvalue 
30 min 
Levobupivacaine 30 30.50 
450 1.00 
Ketamine 30 30.50 
1 Hr 
Levobupivacaine 30 30.50 
450 1.00 
Ketamine 30 30.50 
2 Hr 
Levobupivacaine 30 30.50 
450 1.00 
Ketamine 30 30.50 
3 Hr 
Levobupivacaine 30 31.50 
420 0.154 
Ketamine 30 29.50 
4 Hr 
Levobupivacaine 30 41.00 
135 0.000 
Ketamine 30 20.00 
5 Hr 
Levobupivacaine 28 43.96 
15 0.000 
Ketamine 30 16.00 
6 Hr 
Levobupivacaine 19 39.63 
7.0 0.000 
Ketamine 30 18.75 
8 Hr 
Levobupivacaine 7 33.00 
7.0 0.000 
Ketamine 30 15.73 
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The assessment of  the children’s pain level through non verbal 
scale such as the FLACC pain scale showed that  both  group of 
anaesthesia had a similar post operative pain relief in the immediate 2 
hours after surgery. 
The ketamine group of anaesthesia showed a decrease in the mean 
rank  of  FLACC  pain  score  scale  after  the  2nd hour till the end of 
observation period. 
From this data it can be concluded that there is a statistically significant 
difference between the Levobupivacaine and the ketamine group’s 
median FLACC pain score in the post operative period at 4thHr (U=135, 
p=0.000), 5thHr  (U=15, p=0.000), 6thHr  (U=97.5, p=0.000) and 8thHr 
(U=7, p=0.000). 
  It can be further concluded that the ketamine administered 
children elicited statistically significant lower FLACC pain score than 
the Levobupivacaine administered group. 
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Figure No 13: Post operative FLACC pain score 
0
5
10
15
20
25
30
35
40
45
50
30 
min
1  hr 2  hr 3  hr 4  hr 5  hr 6  hr 8  hr
L
K
 
70 
Table No 16: Post operative Ramsay Sedation Scale (Mann-Whitney Test). 
Time Group N 
Mean 
Rank 
Mann-
Whitney 
Test 
Pvalue 
30 min 
Levobupivacaine 30 31.5 
420 0.305 
Ketamine 30 29.5 
1 Hr 
Levobupivacaine 30 28 
375 0.198 
Ketamine 30 33 
2 Hr 
Levobupivacaine 30 24.3 
264 0.001 
Ketamine 30 36.7 
3 Hr 
Levobupivacaine 30 23.3 
234 0.000 
Ketamine 30 37.7 
4 Hr 
Levobupivacaine 30 22.23 
202 0.000 
Ketamine 30 38.77 
5 Hr 
Levobupivacaine 28 19.45 
138.5 0.000 
Ketamine 30 38.88 
6 Hr 
Levobupivacaine 19 14.79 
91 0.000 
Ketamine 30 31.47 
8 Hr 
Levobupivacaine 7 5.00 
7 0.000 
Ketamine 30 22.27 
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The above table shows that the Ramsay Sedation Scale in the post 
operative period. In the 1st 30 min the Levobupivacaine group showed a 
higher Ramsay sedation scale score than the Ketamine group but there 
was no significant difference in their median Ramsay Sedation scale 
score (U=420, p=0.305). 
Further measurement showed that the ketamine group had a 
greater Ramsay Sedation Scale Score at 1st, 2nd, 3rd, 4th 5th, 6th and 8thhr 
of post operative period. 
           It can also be seen that statistically significant difference between 
the Levobupivacaine and ketamine group’s median Ramsay Sedation 
Scale  score  in  the  2ndHr(U=264, p=0.001), 3rdHr(U=234, p=0.000), 
4thHr(U=202, p=0.000), 5thHr(U=138.5, p=0.000), 6thHr(U=91, 
p=0.000) and 8thHr(U=7, p=0.000).  
           It can be also stated that Ketamine administered group had a 
statistically significant higher Ramsay Sedation Scale score after the 2nd 
hour in the post operative period as compared with the Levobupivacaine 
group. 
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Figure No 14: Post-operative Ramsay Sedation Scale 
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Table No 17: Duration of analgesia (Independent Samples Test). 
Group N Mean 
Std. 
Deviation 
T 
p 
value 
95% 
Confidence 
Interval 
Lower Upper 
Levobupivacaine 30 5.93 1.015 -
15.206 
.000 -5.055 -3.879 
Ketamine 30 10.40 1.248 
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This table shows the mean duration of analgesia action exerted by 
the two groups of anaesthetic agents. It can be seen that the mean 
duration of analgesia is greater in the Ketamine group {m= 10.40 
(1.248)} than the Levobupivacaine group {m= 5.93 (1.015)}. 
A t test reveals a statistically significant difference between the 
mean duration of analgesia of the ketamine group and the 
Levobupivacaine group. (t = 15.206, p = 0.000, Į = 0.05) 
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DISCUSSION 
Caudal epidural anaesthesia is an effective means of providing 
post operative  analgesia in children. In this study, I found that  addition 
of ketamine in the of 0.5 mg/kg with 0.25 % of levobupivacaine  1ml/kg 
increases the duration of post operative analgesia . 
 Locatelli4 observed caudal block with levobupivacaine and 
ketamine gives longer analgesia than caudal block with levobupivacaine 
alone. 
The main disadvantage of caudal anaesthesia is the short duration 
of action after a single injection of local anaesthetic solution. Even long 
acting local anaesthetic drugs such as bupivacaine provide only 4 – 8 
hours of analgesia. 
  The use of caudal catheters for administering repeated doses or 
infusion of local anaesthetic solution is not popular because of concerns 
about infection. Prolongation of caudal analgesia using a single shot 
technique have been achieved by the addition of various adjuvants. 
 Caudal epidural anaesthesia provide good postoperative 
analgesia. Thus  it reduces general anaesthesia’s requirement and 
providing a smooth pain free awakening. 
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 It diminishes the potential risk associated with deeper planes of 
anaesthesia. In short cases, it can help to avoid airway instrumentation. 
It provides faster and comfortable wake up times in the operating room, 
quicker discharge and thus faster turn around time in the post 
anaesthetic care unit. 
It provide optimal postoperative analgesia as a part of a balanced  
multimodal approach to pain management, which includes paracetamol, 
non pharmacological support and occasionally opiod. 
 Even a single dose of opioid can cause vomiting and respiratory 
depression, it should be avoided as much as possible .Thus, regional 
blocks can reduce the incidence of vomiting.  It reduces undesirable 
reflexes associated with the anal sphincter and testis which can cause 
laryngospasm. 
In this study, I have used ketamine at a lower dose of 0.5 mg/kg 
in addition to levobupivacaine for caudal epidural block in order to 
avoid systemic side effects. Intravenous analgesic dose of ketamine is 
more than caudal dose. In addition , it has lesser duration of action and 
comparatively more side effects. 
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LIMITATIONS OF CAUDAL USE OF KETAMINE : 
It is preferable to use it as additive to local anaesthetic because it 
needs to be used in higher dose to make to act as a sole anaesthetic. In 
case if it is used solely , risk of systemic toxicity is more because of 
more systemic absorbtion.   
Its usage is restricted as single shot bolus only, because 
continuous infusion through an epidural catheter is not advisable since it 
produces damage to neural tissue. 
Some investigators blame the preservatives like benzethonium 
chloride and chlorbutanol, used in ketamine for producing neuro 
toxicity. So it is better to use preservative free ketamine whenever 
possible. 
In this study.  I found that  duration of postoperative analgesia in 
ketamine group was prolonged .The mean duration of post operative 
analgesia in ‘k’ group was 10.40 and that of ‘L’ group was 5.93  .  The 
‘P’ value is<0.05. 
These finding were similar to the results  of  another study done 
by cook and colleagues1 which reports that addition of ketamine 
0.5mg/kg to bupivacaine 0.25%  ( 1 ml/kg ) provides longer mean 
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duration of postoperative analgesia after orchidopexy [ 12.5 hrs ] than 
clonidine 2 micro gm/ kg [ 5.8 hrs , p < 0.05 ] or epinephrine 5 micro 
gm / ml [ 3.2 hrs, p<0.001 ]. 
Naquib and collegues8  compared the analgesic effect of 
bupivacaine 0.25% [1ml/kg ] with and without ketamine 0.5 mg/kg in 
children undergoing herniotomy. Although there was no significant 
difference in the quality of analgesia , only 7 % of patients who received 
the ketamine and bupivacaine combination required any further 
analgesia in the first 24 hrs after surgery, compared with 20%  and  50% 
respectively of children who received ketamine and bupivacaine only 
groups.  
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SUMMARY 
  From this prospective double blinded study conducted on 60 
patients who   underwent elective lower abdominal surgery, we tried to 
evaluate the effect of the preservative free ketamine on the duration of 
analgesia and intra operative and post operative hemodynamics when 
used with levobupivacaine for caudal epidural block. The summary of 
our findings are 
1. It can be seen that the mean duration of analgesia is greater in the 
Ketamine group {m= 10.40 (1.248)} than the Levobupivacaine 
group {m= 5.93 (1.015)} which was found to be statistically 
significant. 
2. Post operative  FLACC pain score and  Ramsay  sedation scale is 
comparable between both groups upto 2 hours. After that, there is 
significant difference between both groups[ p value < 0.05 ]. 
3. In both the groups , haemodynamic changes in intra operative and 
post operative period were comparable and insignificant. 
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CONCLUSION 
From our study we conclude that administration of preservative 
free ketamine with levobupivacaine in caudal epidural block increases 
the duration of post operative analgesia without significantly altering 
the hemodynamics compared  with levobupivacaine alone.  Thus low 
dose preservative free ketamine can be used as additive to local 
anaesthetics in caudal epidural anaesthesia for prolonging analgesic 
effect.  
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PROFORMA 
Date:      Roll no:    Group 
Name:    Age/Sex:     IP no: 
Wt:      
Diagnosis: 
Surgical Procedure done: 
Pre op assessment: 
History: 
Any H/O co-morbid illness 
Any H/O previous surgery 
O/E:      CVS:     RS: 
BP:      PR:      SPO2: 
ASA status: 
Drugs used: 
Induction:        
 Maintenance: 
Time of administration of caudal block: 
Duration of surgery: 
Intra OP events: 
Time Events HR BP SPO2 
     
     
     
     
 Post OP events 
Time(Hrs) HR BP Pain Score Sedation Score 
     
     
     
     
 
 
Complication: 
Group Respiratory 
Depression 
Apnea Pruitis Urinary 
Retention 
Nausea & 
Vomiting 
      
 
 
 
 
 
 
 
 
 
INFORMATION  TO  PARTICIPANTS FORM 
 
Investigator                     : Dr.S.SARAVANAN 
Name of the Participant: 
Title:     “Effect of Preservative Free Ketamine with Levobupivacaine for Caudal 
Block in Lower Abdominal Surgeries in Children “ 
Your child are invited to take part in this research study. We have got approval 
from the IEC. Your child are asked to participate because he satisfy the eligibility criteria 
.We want to study the benefits of preservative free ketamine with levobupivacaine for 
caudal block. 
What is the Purpose of the Research: 
            Compares the efficacy and safety of  caudal epidural administration of 
preservative free ketamine with levobupivacaine vs levobupivacaine alone.  
  
The Study Design: 
All the patients are randomly allocated into two groups. 
 Benefits: 
Systemic side effects of ketamine avoided, increased duration of post-operative 
pain relief. 
Discomforts and risks: 
Hypotension and allergic to levobupivacaine in rare patients can occur. These can 
be promptly recognised and treatable. 
This intervention has been shown to be well tolerated as shown by previous 
studies. And if you do not want to participate your child will have alternative of setting 
the standard treatment and your safety is our prime concern. 
Time : 
Date : 
Place :      Signature / Thumb Impression of 
parent 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
ETHICAL  COMMITTEE  CERTIFICATE OF 
APPROVAL 
 
 
MASTER CHART 
KETAMINE GROUP: 
S.No Name Age Sex Wt Dur of surg Surgery ASA 
1 GOKUL 2 M 11 25 RT ENCYSTED HYDROCELE 1 
2 SANJAY 2.5 M 10 30 RT INGUINAL HERNIA 1 
3 HARINI 6 F 15 30 RT INGUINAL HERNIA 1 
4 SAKTHIVEL 1 M 11 60 LT INGUINAL HERNIA 1 
5 MANIKANDAN 3.5 M 14 60 LT HYDROCELE 1 
6 MANIKANDAN 7 M 17 60 B/L HYDROCELE 1 
7 TIRISH 1.5 M 9 30 RT HYDROCELE 1 
8 SANJAY 2.5 M 10 30 RT HYDROCELE 1 
9 RUPESH 5 M 14 35 LT HYDROCELE 1 
10 
LAXMI 
NARAYANAN 
6 M 15 25 LT INGUINAL HERNIA 1 
11 DHARSAN 4 M 13 35 LT INGUINAL HERNIA 1 
12 SANTHOSH 4.5 M 17 40 RT ENCYSTED HYDROCELE 1 
13 MAHAVISHNU 2 M 10 45 
LT CONGENITAL 
HYDROCELE 
1 
14 SHYAM 4 M 11 20 RT INGUINAL HERNIA 1 
15 VASANTHAKUMAR 8 M 17 45 RT HYDROCELE 1 
16 JAWAHAR 6 M 16 30 LT HYDROCELE 1 
17 ADITHYA 6 M 17 20 RT INGUINAL HERNIA 1 
18 MANIKANDAN 4.5 M 14 30 LT INGUINAL HERNIA 1 
19 HARISH RAGAVAN 2.5 M 10 20 
LT CONGENITAL 
HYDROCELE 
1 
20 ABUBAKAR 1.5 M 10 60 RT INGUINAL HERNIA 1 
21 TAMIL 2 M 10 25 LT INGUINAL HERNIA 1 
22 ARUNKUMAR 8 M 20 20 LT INGUINAL HERNIA 1 
23 SUMANRAJ 4 M 15 40 RT HYDROCELE 1 
24 MADHAN 8 M 20 35 RT INGUINAL HERNIA 1 
25 SUNIL 7 M 15 30 RT HYDROCELE 1 
26 RUTHICK 4.5 M 15 40 RT HYDROCELE 1 
27 VINAY 6 M 14 25 RT INGUINAL HERNIA 1 
28 TAMILVENDAN 4 M 15 25 LT HYDROCELE 1 
29 RAJADURAI 8 M 18 45 RT INGUINAL HERNIA 1 
30 SANTHOSH 8 M 19 35 RT INGUINAL HERNIA 1 
 
 
 
 
 
 LEVOBUPIVACAINE GROUP: 
S.N
o 
Name Age Sex Wt 
Dur of 
surg 
Surgery 
AS
A 
1 MOHAMED IMRAN                                                                                           2 M                                     10 45 LT HYDROCELE                                                    1
2 BHUVANESHKUMAR                                                                             2.5 M                                                                                      12 60 LT INGUINAL HERNIA                                                           1
21 RITHISH                                                                    3 M                                                   15 25 LT HYDROCELE                                                1
22 DEEPAK SHARAN                                                1 M                                         11 35 
RT CONGENITAL 
HYDROCELE                                                                                                                                                           1 
23 
STEPHAN 
MADHAVAN                               7 M                                            17 40 LT INGUINAL HERNIA                     1 
24 SUMAIYA                          2 F                              10 35 LT INGUINAL HERNIA                                                                                                                                    1
25 PRASHANTH                                                                                                                                       1 M 12 25 RT INGUINAL HERNIA                                                                                                   1 
37 ABINESH                                                                                                                           3 M                                                  12 45 LT INGUINAL HERNIA                                                         1
38 KANISHA                                                                                                                      4 M                                                   13 30 LT INGUINAL HERNIA                                                                          1
39 VAISHNAVI                                                                                                                    5 F                                                                                                                            15 20 RT INGUINAL HERNIA                                                              1 
40 SAKTHIVEL                                                                                                                    2 M                                                  11 25 LT HYDROCELE                                                                            1
41 YUVARAJ                                                                                                                      3 M                                                   14 30 LT HYDROCELE                                                                            1
42 VEERAMANI                                                                                                                    2.5 M                                               12 25 LT HYDROCELE                                                                            1
43 DEVANAD                                                                                                                      3 M                                                 13 35 RT HYDROCELE                                                                  1
44 UDHAYAKUMAR                                                                                                                  2 M                                                                                                                            10 20 LT HYDROCELE                                                                            1
45 MOHAMED USHMAN                                                                                                               2 M                                                                                                                            10 20 RT HYDROCELE                                                       1
46 VALLARASAN                                                                                                                   2 M                                                                                                                            9 25 LT HYDROCELE                                                                            1
47 SUNIL                                                                                                                   6 M                                                    17 35 LT INGUINAL HERNIA                                                                    1
48 GANESHWAR                                                                                                 1.5 M                                         8 20 RT HYDROCELE                                                       1
49 VIGNESH                                                                                    2 M                                                 9 35 RT INGUINAL HERNIA                                                       1 
50 SATHESH                                                                       6 M                                                 18 25 LT HYDROCELE                                                1
51 SAIPROMOTH                                                      1.5 M                                         8 30 LT INGUINAL HERNIA                                     1
52 AJAYKRISHNAN                                     1.5 M                                         9 20 LT HYDROCELE                            1 
53 VISHWAJITH                        1.5 M                             7 40 RT INGUINAL HERNIA                                                                                                                                    1 
54 JAYACHANDRAN                                                                                                                                    7 M              1 20 RT INGUINAL HERNIA                                                                                               1
55 KAMESH SUNDAR                                                                                                                       7 M                                      18 30 RT HYDROCELE                                                   1
56 MUTHUKRISHNAN                                                                                                                4 M                                        15 35 RT HYDROCELE                                                                          1
57 VIKAS                                                                                                                        5 M                                                                                                                            15 25 RT INGUINAL HERNIA                                                            1
58 JEEVANDAN                                                                                                                    2.5 M                                               11 20 RT INGUINAL HERNIA                                                             1
59 DINESH                                                                                                                       3.5 M                                                                                                                            15 20 LT HYDROCELE                                                                            1
60 KUMAR 8 M 19 35 RT INGUINAL HERNIA  
  
 
 
 
 KETAMINE GROUP: 
TIME OF 
ADMINISTRATION 
POST- OP COMPLICATION 
Induction Caudal 
Resp 
Depression 
Apnoea 
Urinary 
retention 
Nausea Vomitting 
9.45a.m 9.50a.m NIL NIL NIL NIL NIL 
10.40a.m 10.45a.m NIL NIL NIL NIL NIL 
11.30a.m 11.35a.m NIL NIL NIL NIL NIL 
9.30a.m 9.35a.m NIL NIL NIL NIL NIL 
10.30a.m 10.35a.m NIL NIL PRESENT NIL NIL 
11.40a.m 11.45a.m NIL NIL NIL NIL NIL 
9.05a.m 9.10a.m NIL NIL NIL NIL NIL 
9.25a.m 9.30a.m NIL NIL NIL PRESENT PRESENT 
9.40a.m 9.45a.m NIL NIL PRESENT NIL NIL 
10.05am 10.10a.m NIL NIL NIL NIL NIL 
10.25a.m 10.30a.m NIL NIL NIL PRESENT PRESENT 
9.15 a.m 9.20 a.m NIL NIL NIL NIL NIL 
9.10a.m 9.15a.m NIL NIL NIL NIL NIL 
9.45a.m 9.50a.m NIL NIL NIL NIL NIL 
9.50a.m 9.55a.m NIL NIL NIL NIL NIL 
10.45a.m 10.50a.m NIL NIL NIL NIL NIL 
9.45a.m 9.50 a.m NIL NIL NIL PRESENT PRESENT 
10.10 a.m 
10.15 
a.m 
NIL NIL NIL NIL NIL 
10.30 a.m 
10.35 
a.m 
NIL NIL NIL NIL NIL 
11.00 a.m 
11.05 
a.m 
NIL NIL NIL NIL NIL 
10.45 a.m 
10.50 
a.m 
NIL NIL NIL NIL NIL 
11.15 a.m 
11.20 
a.m 
NIL NIL NIL PRESENT PRESENT 
9.45 a.m 9.50 a.m NIL NIL NIL NIL NIL 
10.25 a.m 
10.30 
a.m 
NIL NIL PRESENT NIL NIL 
11.10 a.m 
11.15 
a.m 
NIL NIL NIL NIL NIL 
9.15 a.m 9.20 a.m NIL NIL NIL NIL NIL 
10.20a.m 
10.25 
a.m 
NIL NIL NIL NIL NIL 
11.15 a.m 
11.20 
a.m 
NIL NIL NIL NIL NIL 
10.15 a.m 
10.20 
a.m 
NIL NIL NIL NIL NIL 
10.10a.m 10.15am NIL NIL NIL NIL NIL 
 LEVOBUPIVACAINE GROUP: 
TIME OF ADMINISTRATION POST- OP COMPLICATION 
Induction Caudal Resp Depression Apnoea Urinary retention Nausea Vomitting 
9.30a.m                                                                                                                      9.40a.m                            NIL                                                                                                                          NIL                              NIL                    NIL                                                                                NIL                       
10a.m                                                                                                                        10.10a.m                                                                                                                     NIL                      NIL                              NIL                    NIL                                                                                NIL                       
9.20 a.m 9.25 a.m NIL                                                                                                                          NIL                              NIL                    NIL                                                                                NIL                       
9.50 a.m 9.55 a.m NIL                                                                                                                          NIL                              NIL                    NIL                                                                                NIL                       
10.15 a.m 10.20 a.m NIL                                                                                                                        NIL                              PRESENT                          NIL                                                                  NIL                                     
10.25 a.m 10.30 a.m NIL                                                                                                   NIL                              NIL                    NIL                                                                                NIL                       
9.40 a.m 9.45a.m                                                                                     NIL                       NIL                                                                   NIL                    NIL                                                                                NIL                       
9.30a.m                                                                                    9,.35a.m                            NIL                                     NIL                                                                  NIL                    PRESENT                                                                                  PRESENT                       
9.40a.m                                                                                   9.45a.m                            NIL                                                                                       NIL                              NIL                    NIL                                                                                NIL                       
11.30a.m                                                                                 11.35a.m                            NIL                      NIL                                      NIL                    NIL                                                                                NIL                       
11a.m                                                                                   11.05am                                                                                 NIL                      NIL                                                            NIL                    NIL                                                                                NIL                       
10.20a.m                                                                               10.25a.m                            NIL                      NIL                              PRESENT                          NIL                                                                                NIL                       
9.55a.m                                                                               10a.m                                                                                 NIL                                                  NIL                              NIL                    NIL                                                                                NIL                       
10.10a.m                                                                             10.15a.m                            NIL                      NIL                                  NIL                    NIL                                                                                NIL                       
11.15a.m                                                                            11.20a.m                            NIL                      NIL                              NIL                    NIL                                                                                NIL                       
11.25a.m                                                                           11.30a.m                            NIL                      NIL                              NIL                    NIL                                                                                NIL                       
10a.m                                                                             10.05am                                                                           NIL                      NIL                                                          NIL                    NIL                                                                               NIL                       
10.25a.m                                                                         10.30a.m                            NIL                      NIL                              NIL                    NIL                                                                              NIL                       
10.25a.m                                                                        10.30a.m                            NIL                      NIL                              PRESENT                          NIL                                                                             NIL                       
10.45a.m                                                                       10.50a.m                            NIL                      NIL                              NIL                    NIL                                                                            NIL                       
9.50a.m                                                                       9.55a.m                            NIL                                               NIL                                                     NIL                    NIL                                                                           NIL                       
9.55a.m                                                                      10a.m                                                                        NIL                                                  NIL                              NIL                    NIL                                                                          NIL                       
12.05pm                                                                     12.10pm                            NIL                      NIL                              NIL                    NIL                                                                         NIL                       
12pm                                                                       12.05pm                                                                    NIL                      NIL                              NIL                    NIL                                                                        NIL                       
11.40a.m                                                                  11.45a.m                            NIL                      NIL                              NIL                    NIL                                                                       NIL                       
10a.m                                                                    10.05a.m                                                               NIL                      NIL                              NIL                    NIL                                                                      NIL                       
10.30a.m                                                                10.35a.m                            NIL                      NIL                              NIL                    NIL                                                                     NIL                       
10a.m                                                                  10.05am                                                                NIL                      NIL                                               NIL                    NIL                                                                    NIL                       
11.20a.m                                                              11.25a.m                            NIL                      NIL                              NIL                    NIL                                                                   NIL                       
9.40a.m                                                              9.45a.m                            NIL                       NIL                                            NIL                    NIL                                                                  NIL                       
 
 
 
 
 
 KETAMINE GROUP – INTRA OPERATIVE BP (Systolic) 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
90 100 97 89 81 82 
     
114 60 82 80 80 84 84 
    
112 98 99 108 91 91 88 
    
102 63 85 80 81 82 84 82 82 86 86 
82 93 89 90 88 86 82 84 83 84 86 
130 100 81 78 77 78 80 80 84 80 82 
102 88 85 80 81 82 84 
    
82 80 78 78 78 80 78 
    
104 102 100 98 96 94 98 94 
   
101 80 84 79 80 82 
     
78 78 80 82 84 82 88 88 
   
118 108 102 100 98 98 100 102 100 
  
109 88 90 90 90 92 88 86 90 90 
 
96 86 88 90 92 
      
118 116 110 104 100 98 98 92 90 90 
 
92 94 90 88 88 90 87 
    
88 90 92 86 86 
      
96 94 88 88 86 86 86 
    
96 90 88 88 86 
      
85 84 82 82 84 86 84 84 80 78 78 
84 88 90 86 88 84 
     
110 108 102 100 98 
      
98 99 96 94 90 90 88 89 90 
  
114 110 104 106 106 106 100 98 
   
102 100 96 94 94 92 90 
    
98 98 94 95 92 90 90 88 88 
  
101 98 94 92 90 86 
     
90 99 90 86 86 88 
     
112 110 106 102 104 106 100 98 98 98 
 
106 102 104 100 96 96 98 96 
   
 
 
 
 
 
  
KETAMINE GROUP – INTRA OPERATIVE BP (Diastolic) 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
44 50 47 45 46 44 
     
68 33 42 45 44 49 49 
    
56 55 54 52 37 46 44 
    
82 46 51 52 51 52 52 54 56 54 56 
46 60 57 58 57 58 52 54 51 54 54 
74 70 48 42 41 42 44 46 48 50 50 
82 46 51 52 51 52 52 
    
64 60 50 48 46 48 44 
    
68 64 66 58 55 52 56 52 
   
80 44 50 50 49 52 
     
42 40 44 44 50 44 50 48 
   
82 72 70 68 68 66 68 70 70 
  
78 68 66 70 68 64 60 64 64 64 
 
58 44 50 52 50 
      
78 76 70 74 70 68 64 62 60 64 
 
54 54 50 48 50 50 48 
    
60 60 60 58 56 
      
58 56 54 54 52 53 54 
    
70 66 58 56 54 
      
68 68 66 60 58 58 59 60 58 56 60 
58 56 56 58 54 52 
     
80 76 78 74 74 
      
68 70 66 64 64 58 58 58 58 
  
80 76 74 75 76 74 70 72 
   
76 74 60 66 66 62 58 
    
70 66 62 60 58 56 56 58 58 
  
80 76 74 74 70 65 
     
64 62 60 56 54 56 
     
74 70 68 60 62 60 60 56 58 60 
 
70 66 64 64 60 58 56 54 
   
 
 
 
 
KETAMINE GROUP – INTRA OPERATIVE BP (MAP) 
0 min 5 min 10 min 15 min 20 min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
59.33 66.67 63.67 59.67 57.67 56.67      
83.33 42.00 55.33 56.67 56.00 60.67 60.67     
74.67 69.33 69.00 70.67 55.00 61.00 58.67     
88.67 51.67 62.33 61.33 61.00 62.00 62.67 63.33 64.67 64.67 66.00 
58.00 71.00 67.67 68.67 67.33 67.33 62.00 64.00 61.67 64.00 64.67 
92.67 80.00 59.00 54.00 53.00 54.00 56.00 57.33 60.00 60.00 60.67 
88.67 60.00 62.33 61.33 61.00 62.00 62.67     
70.00 66.67 59.33 58.00 56.67 58.67 55.33     
80.00 76.67 77.33 71.33 68.67 66.00 70.00 66.00    
87.00 56.00 61.33 59.67 59.33 62.00      
54.00 52.67 56.00 56.67 61.33 56.67 62.67 61.33    
94.00 84.00 80.67 78.67 78.00 76.67 78.67 80.67 80.00   
88.33 74.67 74.00 76.67 75.33 73.33 69.33 71.33 72.67 72.67  
70.67 58.00 62.67 64.67 64.00       
91.33 89.33 83.33 84.00 80.00 78.00 75.33 72.00 70.00 72.67  
66.67 67.33 63.33 61.33 62.67 63.33 61.00     
69.33 70.00 70.67 67.33 66.00       
70.67 68.67 65.33 65.33 63.33 64.00 64.67     
78.67 74.00 68.00 66.67 64.67       
73.67 73.33 71.33 67.33 66.67 67.33 67.33 68.00 65.33 63.33 66.00 
66.67 66.67 67.33 67.33 65.33 62.67      
90.00 86.67 86.00 82.67 82.00       
78.00 79.67 76.00 74.00 72.67 68.67 68.00 68.33 68.67   
91.33 87.33 84.00 85.33 86.00 84.67 80.00 80.67    
84.67 82.67 72.00 75.33 75.33 72.00 68.67     
79.33 76.67 72.67 71.67 69.33 67.33 67.33 68.00 68.00   
87.00 83.33 80.67 80.00 76.67 72.00      
72.67 74.33 70.00 66.00 64.67 66.67      
86.67 83.33 80.67 74.00 76.00 75.33 73.33 70.00 71.33 72.67  
82.00 78.00 77.33 76.00 72.00 70.67 70.00 68.00    
 LEVOBUPIVACAINE GROUP – INTRA OPERATIVE BP (Systolic) 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
90 84 82 85 80 80 82 84 80 84 
 
82 80 78 78 78 76 78 78 78 76 78 
86 87 88 84 82 82 
     
78 80 80 76 78 78 76 76 
   
108 106 100 99 96 98 98 96 98 
  
90 88 88 87 86 86 84 84 
   
84 86 86 84 84 82 
     
78 80 82 78 76 76 76 74 74 76 
 
97 98 94 92 90 90 88 
    
102 100 96 94 90 
      
98 88 86 86 84 84 
     
93 82 88 88 86 84 86 
    
88 78 86 86 84 82 
     
96 86 86 84 82 82 84 82 
   
89 84 83 80 78 
      
85 80 78 80 78 
      
102 88 88 86 80 78 
     
104 100 96 92 90 88 90 86 
   
81 68 78 78 76 
      
87 86 84 86 84 80 80 80 
   
97 88 90 87 86 86 
     
96 84 82 84 84 82 80 
    
87 88 84 84 82 
      
96 88 86 86 84 80 76 78 76 
  
104 100 94 94 92 
      
112 102 100 96 96 96 95 
    
97 86 92 92 90 88 89 90 
   
89 76 86 84 84 82 
     
98 86 86 80 82 
      
100 86 88 84 82 
      
 
 
 
 
 
 LEVOBUPIVACAINE GROUP – INTRA OPERATIVE BP (Diastolic) 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
50 34 39 49 44 40 42 44 40 46 
 
60 54 48 46 44 42 44 44 46 44 44 
56 53 54 52 52 50 
     
54 54 52 52 49 48 48 48 
   
76 76 75 68 68 66 64 64 63 
  
58 60 58 56 56 54 49 48 
   
58 54 55 54 52 50 
     
58 58 60 56 56 54 54 54 56 52 
 
64 66 60 60 58 58 56 
    
74 72 70 66 62 
      
64 64 60 56 54 52 
     
64 58 60 56 56 54 54 
    
62 50 58 56 54 54 
     
70 66 64 62 60 58 58 58 
   
66 64 62 62 60 
      
65 60 58 58 56 
      
70 66 68 64 60 60 
     
72 70 64 60 58 56 56 54 
   
58 46 56 54 54 
      
60 58 56 54 56 54 52 50 
   
64 62 60 58 56 54 
     
68 56 56 58 54 52 54 
    
60 56 50 48 50 
      
70 64 64 62 60 56 54 54 50 
  
70 66 64 62 60 
      
76 66 64 62 62 60 60 
    
64 54 60 62 60 58 58 56 
   
62 54 64 62 60 58 
     
70 66 64 58 58 
      
68 58 58 56 56 
      
 
 
 
 
 
 LEVOBUPIVACAINE GROUP – INTRA OPERATIVE BP (MAP) 
0 min 5 min 10 min 15 min 20 min 25 min 30 min 35 min 40 min 45 min 60 min 
63.33 50.67 53.33 61.00 56.00 53.33 55.33 57.33 53.33 58.67 
 
67.33 62.67 58.00 56.67 55.33 53.33 55.33 55.33 56.67 54.67 55.33 
66.00 64.33 65.33 62.67 62.00 60.67 
     
62.00 62.67 61.33 60.00 58.67 58.00 57.33 57.33 
   
86.67 86.00 83.33 78.33 77.33 76.67 75.33 74.67 74.67 
  
68.67 69.33 68.00 66.33 66.00 64.67 60.67 60.00 
   
66.67 64.67 65.33 64.00 62.67 60.67 
     
64.67 65.33 67.33 63.33 62.67 61.33 61.33 60.67 62.00 60.00 
 
75.00 76.67 71.33 70.67 68.67 68.67 66.67 
    
83.33 81.33 78.67 75.33 71.33 
      
75.33 72.00 68.67 66.00 64.00 62.67 
     
73.67 66.00 69.33 66.67 66.00 64.00 64.67 
    
70.67 59.33 67.33 66.00 64.00 63.33 
     
78.67 72.67 71.33 69.33 67.33 66.00 66.67 66.00 
   
73.67 70.67 69.00 68.00 66.00 
      
71.67 66.67 64.67 65.33 63.33 
      
80.67 73.33 74.67 71.33 66.67 66.00 
     
82.67 80.00 74.67 70.67 68.67 66.67 67.33 64.67 
   
65.67 53.33 63.33 62.00 61.33 
      
69.00 67.33 65.33 64.67 65.33 62.67 61.33 60.00 
   
75.00 70.67 70.00 67.67 66.00 64.67 
     
77.33 65.33 64.67 66.67 64.00 62.00 62.67 
    
69.00 66.67 61.33 60.00 60.67 
      
78.67 72.00 71.33 70.00 68.00 64.00 61.33 62.00 58.67 
  
81.33 77.33 74.00 72.67 70.67 
      
88.00 78.00 76.00 73.33 73.33 72.00 71.67 
    
75.00 64.67 70.67 72.00 70.00 68.00 68.33 67.33 
   
71.00 61.33 71.33 69.33 68.00 66.00 
     
79.33 72.67 71.33 65.33 66.00 
      
78.67 67.33 68.00 65.33 64.67 
      
 
 
 
 
 
 
KETAMINE GROUP – INTRA OPERATIVE PR 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
114 122 124 122 120 117 
     
110 83 84 83 88 90 92 
    
106 104 96 107 80 77 76 
    
106 102 100 96 92 90 94 88 96 95 93 
96 117 83 82 82 80 73 74 76 84 80 
92 94 114 93 91 94 96 98 100 99 101 
106 102 100 96 90 90 88 
    
128 110 116 108 109 106 109 
    
112 108 114 113 108 103 106 110 
   
104 100 91 94 86 90 
     
98 94 104 104 106 99 98 100 
   
122 123 114 108 109 114 118 123 116 
  
130 112 120 123 118 119 123 112 110 108 
 
114 102 106 98 94 
      
108 114 97 103 99 97 96 90 88 90 
 
96 92 92 90 88 94 86 
    
108 107 110 103 99 
      
124 1124 116 114 108 110 112 
    
126 124 120 114 110 
      
130 126 124 119 120 120 118 118 114 110 112 
118 116 122 110 108 110 
     
98 96 94 90 92 
      
106 110 102 100 101 102 99 98 96 
  
103 105 100 101 98 99 96 96 
   
98 97 99 94 92 90 88 
    
104 102 106 96 93 94 92 94 91 
  
112 106 108 107 102 100 
     
122 120 118 117 108 107 
     
96 98 94 90 92 91 90 89 92 90 
 
99 90 96 92 93 89 88 90 
   
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – INTRA OPERATIVE PR 
0 
min 
5 
min 
10 
min 
15 
min 
20 
min 
25 
min 
30 
min 
35 
min 
40 
min 
45 
min 
60 
min 
114 119 120 122 99 99 94 92 90 89 
106 104 100 94 96 92 94 90 88 90 92 
132 130 118 114 110 109 
138 134 130 122 116 112 109 108 
110 108 98 96 98 99 92 94 90 
129 126 122 120 114 116 114 108 
136 134 128 120 118 110 
117 120 118 112 110 104 102 106 107 100 
124 126 118 110 106 106 104 
118 124 114 106 102 
132 130 118 116 118 112 
123 121 118 117 116 112 107 
137 130 122 118 119 110 
123 128 120 122 118 116 114 112 
130 122 126 120 117 
125 128 120 118 111 
140 128 118 117 113 109 
109 110 102 98 96 97 93 91 
135 128 119 115 109 
127 123 108 109 110 107 105 105 
99 104 97 94 95 90 
125 116 114 119 109 107 108 
134 135 122 117 115 
138 127 126 123 119 118 117 115 112 
107 105 99 97 92 
110 108 97 102 96 92 90 
113 124 114 109 107 109 110 105 
126 122 130 117 115 106 
133 135 127 116 114 
118 117 110 109 107 
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE BP (Systolic) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
86 88 88 90 92 93 94 94 96 98 
84 85 86 88 90 90 92 94 92 
 
88 89 90 91 92 93 94 94 96 
 
84 86 86 88 90 90 94 94 92 96 
84 84 88 90 92 93 94 94 96 98 
84 90 92 94 96 96 97 98 100 
 
84 86 88 90 90 90 88 92 98 
 
80 80 82 80 80 82 86 88 90 
 
90 88 90 90 86 92 94 98 98 
 
90 86 92 100 94 96 94 98 100 102 
88 90 90 92 92 94 94 96 98 
 
100 101 100 104 106 106 106 108 112 116 
90 90 92 94 94 96 96 98 98 104 
90 90 92 92 94 94 96 94 100 
 
90 90 92 92 94 96 96 98 104 
 
92 90 92 92 94 96 96 104 106 
 
86 84 84 83 86 86 86 88 94 100 
86 88 84 84 88 89 90 94 
  
86 86 88 90 92 90 92 94 94 102 
78 78 80 80 82 86 88 90 90 98 
84 84 86 87 89 90 90 95 95 
 
98 98 100 100 100 102 110 112 
  
90 90 94 94 96 98 100 104 104 
 
98 96 94 96 99 100 102 105 106 
 
90 88 90 92 94 96 96 99 99 108 
88 88 86 88 90 92 92 96 96 105 
86 88 84 85 88 90 94 94 96 102 
86 84 86 87 87 90 92 94 94 
 
98 98 96 99 99 100 102 106 106 112 
96 94 94 96 96 98 100 100 100 111 
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE BP (Diastolic) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
46 48 50 52 54 54 55 56 56 60 
50 52 54 56 58 52 54 58 54 
 
44 45 46 46 46 46 46 46 44 
 
54 54 56 57 58 60 56 60 60 62 
54 54 56 60 62 63 64 64 64 64 
46 48 50 54 56 56 58 57 60 
 
54 56 57 58 60 60 60 62 64 
 
46 44 48 48 50 48 52 60 54 
 
52 54 53 50 52 54 56 58 56 
 
54 50 52 60 56 54 56 58 58 60 
48 50 50 52 52 54 56 54 60 
 
70 70 72 70 70 72 74 76 78 80 
64 64 64 64 60 60 63 62 68 70 
50 50 54 54 54 54 54 54 56 
 
64 60 62 64 64 64 66 66 68 
 
64 62 64 64 65 66 67 70 72 
 
56 54 54 54 56 57 60 60 62 64 
54 54 54 56 56 56 60 62 
  
54 56 58 60 60 60 62 64 64 66 
60 62 64 60 62 64 64 64 64 66 
52 54 54 54 56 60 62 64 64 
 
74 76 76 74 76 77 76 76 
  
58 58 56 56 58 60 62 64 64 
 
72 70 70 70 74 74 74 74 74 
 
58 56 56 58 60 62 60 60 60 68 
56 56 54 56 60 62 62 64 64 66 
65 66 65 64 64 64 66 64 64 67 
54 54 56 56 56 58 60 60 60 
 
58 58 56 58 60 62 62 62 62 64 
54 60 60 54 56 58 60 60 60 64 
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE BP (MAP) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
59.33 61.33 62.67 64.67 66.67 67.00 68.00 68.67 69.33 72.67 
61.33 63.00 64.67 66.67 68.67 64.67 66.67 70.00 66.67 
58.67 59.67 60.67 61.00 61.33 61.67 62.00 62.00 61.33 
64.00 64.67 66.00 67.33 68.67 70.00 68.67 71.33 70.67 73.33 
64.00 64.00 66.67 70.00 72.00 73.00 74.00 74.00 74.67 75.33 
58.67 62.00 64.00 67.33 69.33 69.33 71.00 70.67 73.33 
 64.00 66.00 67.33 68.67 70.00 70.00 69.33 72.00 75.33 
 57.33 56.00 59.33 58.67 60.00 59.33 63.33 69.33 66.00 
 64.67 65.33 65.33 63.33 63.33 66.67 68.67 71.33 70.00 
 66.00 62.00 65.33 73.33 68.67 68.00 68.67 71.33 72.00 74.00 
61.33 63.33 63.33 65.33 65.33 67.33 68.67 68.00 72.67 
80.00 80.33 81.33 81.33 82.00 83.33 84.67 86.67 89.33 92.00 
72.67 72.67 73.33 74.00 71.33 72.00 74.00 74.00 78.00 81.33 
63.33 63.33 66.67 66.67 67.33 67.33 68.00 67.33 70.67 
 72.67 70.00 72.00 73.33 74.00 74.67 76.00 76.67 80.00 
 73.33 71.33 73.33 73.33 74.67 76.00 76.67 81.33 83.33 
 66.00 64.00 64.00 63.67 66.00 66.67 68.67 69.33 72.67 76.00 
64.67 65.33 64.00 65.33 66.67 67.00 70.00 72.67 
64.67 66.00 68.00 70.00 70.67 70.00 72.00 74.00 74.00 78.00 
66.00 67.33 69.33 66.67 68.67 71.33 72.00 72.67 72.67 76.67 
62.67 64.00 64.67 65.00 67.00 70.00 71.33 74.33 74.33 
 82.00 83.33 84.00 82.67 84.00 85.33 87.33 88.00 
  68.67 68.67 68.67 68.67 70.67 72.67 74.67 77.33 77.33 
 80.67 78.67 78.00 78.67 82.33 82.67 83.33 84.33 84.67 
 68.67 66.67 67.33 69.33 71.33 73.33 72.00 73.00 73.00 81.33 
66.67 66.67 64.67 66.67 70.00 72.00 72.00 74.67 74.67 79.00 
72.00 73.33 71.33 71.00 72.00 72.67 75.33 74.00 74.67 78.67 
64.67 64.00 66.00 66.33 66.33 68.67 70.67 71.33 71.33 
71.33 71.33 69.33 71.67 73.00 74.67 75.33 76.67 76.67 80.00 
68.00 71.33 71.33 68.00 69.33 71.33 73.33 73.33 73.33 79.67 
 
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE BP (Systolic) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
90 92 94 92 94 90 92 
   
78 80 82 80 80 78 80 80 
  
82 80 84 84 80 86 90 
   
76 76 80 80 84 86 90 92 
  
98 98 96 100 102 106 
    
84 86 86 88 90 90 94 
   
82 82 84 86 86 88 90 94 
  
76 78 76 80 80 80 
    
88 88 88 90 90 90 92 
   
90 90 90 92 92 92 94 99 
  
84 84 86 86 88 90 
    
86 84 84 86 88 94 96 
   
82 80 85 88 90 90 95 
   
82 80 82 84 86 90 
    
78 76 80 82 84 85 88 96 
  
78 80 78 80 80 82 88 
   
78 80 80 82 84 88 
    
86 86 85 86 88 96 
    
76 78 80 80 82 84 87 
   
80 80 82 82 87 93 
    
84 84 84 85 86 88 98 
   
80 80 82 82 82 84 84 92 
  
82 84 86 86 88 96 
    
76 76 80 82 92 
     
92 90 90 94 94 94 102 
   
95 92 94 93 96 96 106 
   
90 90 90 93 94 96 96 106 
  
82 80 84 84 88 89 97 
   
82 82 85 88 96 
     
83 84 84 89 88 97 
    
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE BP (Diastolic) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
42 42 46 44 46 44 44 
   
46 44 46 48 46 46 46 44 
  
50 50 52 54 54 54 56 
   
48 50 50 52 52 54 56 56 
  
63 62 62 64 64 66 
    
48 46 44 45 46 48 50 
   
50 50 52 54 54 56 56 58 
  
54 54 56 58 58 56 
    
60 56 58 58 60 62 62 
   
62 64 64 62 65 64 64 65 
  
52 52 56 56 56 60 
    
54 54 54 54 56 56 58 
   
54 55 56 56 60 58 60 
   
60 60 58 60 62 60 
    
60 60 62 62 64 64 64 66 
  
56 56 60 62 64 58 64 
   
60 60 60 60 60 64 
    
55 55 56 58 58 65 
    
56 59 59 60 62 62 64 
   
50 50 52 54 52 60 
    
55 55 56 56 56 56 62 
   
54 54 56 54 56 60 60 64 
  
50 52 52 54 54 58 
    
50 52 50 54 60 
     
60 60 60 62 62 64 66 
   
60 60 60 60 62 60 65 
   
56 58 57 57 58 60 58 60 
  
58 58 58 60 62 62 64 
   
58 60 60 65 65 
     
55 56 56 58 58 60 
    
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE BP (MAP) 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
58.00 58.67 62.00 60.00 62.00 59.33 60.00 
   
56.67 56.00 58.00 58.67 57.33 56.67 57.33 56.00 
  
60.67 60.00 62.67 64.00 62.67 64.67 67.33 
   
57.33 58.67 60.00 61.33 62.67 64.67 67.33 68.00 
  
74.67 74.00 73.33 76.00 76.67 79.33 
    
60.00 59.33 58.00 59.33 60.67 62.00 64.67 
   
60.67 60.67 62.67 64.67 64.67 66.67 67.33 70.00 
  
61.33 62.00 62.67 65.33 65.33 64.00 
    
69.33 66.67 68.00 68.67 70.00 71.33 72.00 
   
71.33 72.67 72.67 72.00 74.00 73.33 74.00 76.33 
  
62.67 62.67 66.00 66.00 66.67 70.00 
    
64.67 64.00 64.00 64.67 66.67 68.67 70.67 
   
63.33 63.33 65.67 66.67 70.00 68.67 71.67 
   
67.33 66.67 66.00 68.00 70.00 70.00 
    
66.00 65.33 68.00 68.67 70.67 71.00 72.00 76.00 
  
63.33 64.00 66.00 68.00 69.33 66.00 72.00 
   
66.00 66.67 66.67 67.33 68.00 72.00 
    
65.33 65.33 65.67 67.33 68.00 75.33 
    
62.67 65.33 66.00 66.67 68.67 69.33 71.67 
   
60.00 60.00 62.00 63.33 63.67 71.00 
    
64.67 64.67 65.33 65.67 66.00 66.67 74.00 
   
62.67 62.67 64.67 63.33 64.67 68.00 68.00 73.33 
  
60.67 62.67 63.33 64.67 65.33 70.67 
    
58.67 60.00 60.00 63.33 70.67 
     
70.67 70.00 70.00 72.67 72.67 74.00 78.00 
   
71.67 70.67 71.33 71.00 73.33 72.00 78.67 
   
67.33 68.67 68.00 69.00 70.00 72.00 70.67 75.33 
  
66.00 65.33 66.67 68.00 70.67 71.00 75.00 
   
66.00 67.33 68.33 72.67 75.33 
     
64.33 65.33 65.33 68.33 68.00 72.33 
    
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE PR 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
122 120 118 116 122 124 122 118 128 130 
84 82 80 84 90 88 86 90 96 
 
78 80 82 86 89 96 99 97 98 
 
86 86 88 90 94 96 98 97 94 102 
78 76 78 80 80 76 82 84 85 90 
100 102 116 101 103 104 110 106 112 
 
88 86 90 94 96 98 94 102 105 
 
114 110 107 106 103 110 112 117 118 
 
110 108 102 100 108 107 112 109 116 
 
96 90 88 95 101 96 98 100 106 104 
90 90 94 96 94 96 100 102 109 
 
114 110 116 114 110 112 117 119 118 122 
118 116 116 114 110 110 109 115 115 118 
94 92 92 90 93 96 97 98 102 
 
96 96 98 99 96 98 100 102 110 
 
97 98 94 94 93 96 100 103 117 
 
99 96 96 94 95 93 96 99 102 106 
108 106 103 106 104 102 110 115 
  
112 109 108 110 111 113 112 116 114 120 
108 104 105 110 112 110 113 103 116 122 
110 102 100 103 104 105 101 108 115 
 
92 94 90 91 93 95 97 104 
  
102 100 99 102 106 103 105 110 117 
 
99 95 94 96 92 98 93 102 110 
 
90 94 95 95 94 96 90 99 95 102 
94 95 91 96 93 98 102 100 102 110 
100 96 98 95 99 96 100 102 103 109 
107 105 107 108 108 109 110 110 116 
 
91 90 88 88 87 90 92 96 94 100 
88 89 87 89 88 91 92 95 98 108 
 
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE PR 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
94 96 98 96 100 94 98 
   
94 98 100 96 94 94 96 94 
  
109 110 102 100 102 112 116 
   
112 110 110 109 106 110 116 120 
  
96 94 94 93 97 100 
    
114 112 110 115 117 116 120 
   
110 112 105 106 116 118 116 118 
  
104 106 102 105 108 108 
    
106 102 100 102 103 105 110 
   
102 105 107 102 109 108 113 114 
  
112 110 109 112 114 118 
    
110 107 106 107 110 112 117 
   
107 106 105 110 114 112 118 
   
114 112 110 115 114 120 
    
117 115 111 115 117 112 113 122 
  
111 107 105 112 115 116 120 
   
109 105 105 104 110 118 
    
97 96 95 97 100 108 
    
113 113 117 115 114 115 123 
   
107 102 104 104 110 117 
    
90 91 92 96 95 94 102 
   
105 101 103 105 108 109 107 117 
  
115 112 111 110 117 119 
    
118 116 117 115 127 
     
93 94 96 94 92 99 108 
   
91 90 93 94 92 97 110 
   
106 99 97 99 98 100 104 112 
  
105 103 105 105 102 106 116 
   
114 112 111 113 119 
     
107 102 101 105 110 117 
    
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE SPO2 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 
     
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 
     
99 99 99 99 99 99 
    
 
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE SPO2 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 
    
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 
    
99 99 99 99 99 
     
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 
   
99 99 99 99 99 
     
99 99 99 99 99 99 
    
 
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE FLACC PAIN SCORE 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
0 0 0 0 0 0 0 0 3 4 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 0 3 4 
0 0 0 0 0 0 0 2 3 4 
0 0 0 0 0 0 0 3 4 
 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 3 4 
 
0 0 0 0 0 0 2 3 4 
 
0 0 0 0 0 0 0 0 2 4 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 2 3 4 
0 0 0 0 0 0 0 0 3 4 
0 0 0 0 0 0 2 3 4 
 
0 0 0 0 0 0 0 3 4 
 
0 0 0 0 0 0 2 3 4 
 
0 0 0 0 0 0 0 3 3 4 
0 0 0 0 0 0 3 4 
  
0 0 0 0 0 0 0 2 3 4 
0 0 0 0 0 0 0 0 3 4 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 3 4 
  
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 2 4 
 
0 0 0 0 0 0 0 2 3 4 
0 0 0 0 0 0 0 3 3 4 
0 0 0 0 0 0 0 2 2 4 
0 0 0 0 0 0 0 3 4 
 
0 0 0 0 0 0 0 2 2 4 
0 0 0 0 0 0 0 0 2 4 
 
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE FLACC PAIN 
SCORE 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr 
0 0 0 0 2 3 4 
   
0 0 0 0 0 2 3 4 
  
0 0 0 0 2 3 4 
   
0 0 0 0 0 3 3 4 
  
0 0 0 0 3 4 
    
0 0 0 0 2 3 4 
   
0 0 0 0 0 3 3 4 
  
0 0 0 0 3 4 
    
0 0 0 0 2 2 4 
   
0 0 0 0 0 2 3 4 
  
0 0 0 0 3 4 
    
0 0 0 0 2 3 4 
   
0 0 0 0 2 2 4 
   
0 0 0 0 3 4 
    
0 0 0 0 0 0 3 4 
  
0 0 0 0 0 2 4 
   
0 0 0 0 3 4 
    
0 0 0 0 2 4 
    
0 0 0 0 2 2 4 
   
0 0 0 0 3 4 
    
0 0 0 0 2 3 4 
   
0 0 0 0 2 2 3 4 
  
0 0 0 0 3 4 
    
0 0 0 3 4 
     
0 0 0 0 0 3 4 
   
0 0 0 0 0 2 4 
   
0 0 0 0 2 2 3 4 
  
0 0 0 0 0 3 4 
   
0 0 0 3 4 
     
0 0 0 0 2 4 
    
 
 
 
 
 
 
KETAMINE GROUP – POST- OPERATIVE RSS& RESCUE 
ANALGESIA 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr RESCUE ANALGESIA 
5 4 4 3 3 3 2 2 2 1 12 
5 4 3 3 3 3 2 2 2 
 
10 
5 4 4 3 3 2 2 2 1 
 
10 
5 4 4 3 2 2 2 2 2 1 12 
5 4 4 4 3 3 2 2 2 1 12 
5 4 3 3 3 3 3 2 1 
 
10 
5 4 4 4 3 3 2 2 1 
 
10 
5 4 4 4 3 3 2 2 1 
 
10 
5 4 3 3 2 2 2 2 1 
 
10 
5 4 3 3 3 3 2 2 2 1 12 
5 4 4 3 3 3 2 2 1 
 
10 
5 4 4 3 3 3 3 3 2 1 12 
5 4 3 3 3 3 2 2 2 1 12 
5 4 4 4 3 3 2 2 1 
 
10 
5 3 3 3 3 3 2 2 1 
 
10 
5 3 3 3 3 3 3 2 1 
 
10 
4 3 3 3 3 2 2 2 2 1 12 
5 4 4 3 3 2 2 1 
  
8 
5 3 3 3 3 2 2 2 2 1 12 
5 4 4 4 3 3 2 2 2 1 12 
4 3 3 3 2 2 2 2 1 
 
10 
4 3 3 2 2 2 2 1 
  
8 
5 3 3 3 3 2 2 2 1 
 
10 
5 3 3 3 3 3 2 2 1 
 
10 
5 3 3 3 2 2 2 2 2 1 12 
5 3 3 2 2 2 2 2 2 1 12 
5 3 3 3 2 2 2 2 2 1 12 
5 4 3 3 2 2 2 2 1 
 
10 
5 4 4 3 3 3 2 2 2 1 12 
5 4 4 4 3 3 3 2 2 1 12 
 
 
 
 
 
 
LEVOBUPIVACAINE GROUP – POST- OPERATIVE RSS & 
RESCUE ANALGESIA 
30 min 1 hr 2 hr 3 hr 4 hr 5 hr 6 hr 8 hr 10 hr 12 hr RESCUE ANALGESIA 
5 3 3 3 2 2 1 
   
6 
5 4 4 3 3 3 2 1 
  
8 
5 3 3 2 2 2 1 
   
6 
5 4 4 3 3 2 2 1 
  
8 
4 4 3 2 2 1 
    
5 
5 4 4 3 2 2 1 
   
6 
5 3 3 3 3 2 2 1 
  
8 
5 3 2 2 2 1 
    
5 
5 4 3 3 3 2 1 
   
6 
5 4 3 3 2 2 2 1 
  
8 
5 4 3 3 2 1 
    
5 
5 3 3 3 3 2 1 
   
6 
5 4 3 3 2 2 1 
   
6 
5 3 2 2 2 1 
    
5 
5 4 3 3 2 2 2 1 
  
8 
5 4 3 3 2 2 1 
   
6 
5 3 3 3 2 1 
    
5 
5 3 2 2 2 1 
    
5 
5 3 3 3 2 2 1 
   
6 
5 4 3 2 2 1 
    
5 
5 3 3 2 2 2 1 
   
6 
5 4 3 3 3 2 2 1 
  
8 
5 3 3 2 2 1 
    
5 
5 3 2 2 1 
     
4 
5 4 4 3 2 2 1 
   
6 
5 3 3 2 2 2 1 
   
6 
5 4 3 3 2 2 2 1 
  
8 
5 3 3 2 2 2 1 
   
6 
5 3 2 2 1 
     
4 
5 3 2 2 2 1 
    
5 
 
 
 
 
 
